CN111051322A - Stabilized polyolefin compositions comprising benzofuranones and organophosphorus stabilizers - Google Patents

Stabilized polyolefin compositions comprising benzofuranones and organophosphorus stabilizers Download PDF

Info

Publication number
CN111051322A
CN111051322A CN201880056779.5A CN201880056779A CN111051322A CN 111051322 A CN111051322 A CN 111051322A CN 201880056779 A CN201880056779 A CN 201880056779A CN 111051322 A CN111051322 A CN 111051322A
Authority
CN
China
Prior art keywords
sub
alkyl
radical
hydrogen
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201880056779.5A
Other languages
Chinese (zh)
Inventor
R·E·金三世
W·赫茨尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Priority claimed from PCT/US2018/040694 external-priority patent/WO2019010166A1/en
Publication of CN111051322A publication Critical patent/CN111051322A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/49Phosphorus-containing compounds
    • C08K5/51Phosphorus bound to oxygen
    • C08K5/52Phosphorus bound to oxygen only
    • C08K5/524Esters of phosphorous acids, e.g. of H3PO3
    • C08K5/526Esters of phosphorous acids, e.g. of H3PO3 with hydroxyaryl compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/18Oxygen-containing compounds, e.g. metal carbonyls
    • C08K3/20Oxides; Hydroxides
    • C08K3/22Oxides; Hydroxides of metals
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/0008Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
    • C08K5/005Stabilisers against oxidation, heat, light, ozone
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/09Carboxylic acids; Metal salts thereof; Anhydrides thereof
    • C08K5/098Metal salts of carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/10Esters; Ether-esters
    • C08K5/101Esters; Ether-esters of monocarboxylic acids
    • C08K5/103Esters; Ether-esters of monocarboxylic acids with polyalcohols
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/10Esters; Ether-esters
    • C08K5/101Esters; Ether-esters of monocarboxylic acids
    • C08K5/105Esters; Ether-esters of monocarboxylic acids with phenols
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/13Phenols; Phenolates
    • C08K5/134Phenols containing ester groups
    • C08K5/1345Carboxylic esters of phenolcarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/15Heterocyclic compounds having oxygen in the ring
    • C08K5/151Heterocyclic compounds having oxygen in the ring having one oxygen atom in the ring
    • C08K5/1535Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/16Nitrogen-containing compounds
    • C08K5/34Heterocyclic compounds having nitrogen in the ring
    • C08K5/3412Heterocyclic compounds having nitrogen in the ring having one nitrogen atom in the ring
    • C08K5/3432Six-membered rings
    • C08K5/3435Piperidines
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/16Nitrogen-containing compounds
    • C08K5/34Heterocyclic compounds having nitrogen in the ring
    • C08K5/3467Heterocyclic compounds having nitrogen in the ring having more than two nitrogen atoms in the ring
    • C08K5/3477Six-membered rings
    • C08K5/3492Triazines
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/49Phosphorus-containing compounds
    • C08K5/51Phosphorus bound to oxygen
    • C08K5/52Phosphorus bound to oxygen only
    • C08K5/521Esters of phosphoric acids, e.g. of H3PO4
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/49Phosphorus-containing compounds
    • C08K5/51Phosphorus bound to oxygen
    • C08K5/52Phosphorus bound to oxygen only
    • C08K5/521Esters of phosphoric acids, e.g. of H3PO4
    • C08K5/523Esters of phosphoric acids, e.g. of H3PO4 with hydroxyaryl compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/49Phosphorus-containing compounds
    • C08K5/51Phosphorus bound to oxygen
    • C08K5/52Phosphorus bound to oxygen only
    • C08K5/524Esters of phosphorous acids, e.g. of H3PO3
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/49Phosphorus-containing compounds
    • C08K5/51Phosphorus bound to oxygen
    • C08K5/52Phosphorus bound to oxygen only
    • C08K5/527Cyclic esters
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/49Phosphorus-containing compounds
    • C08K5/51Phosphorus bound to oxygen
    • C08K5/52Phosphorus bound to oxygen only
    • C08K5/529Esters containing heterocyclic rings not representing cyclic esters of phosphoric or phosphorous acids
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L23/00Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • C08L23/02Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
    • C08L23/04Homopolymers or copolymers of ethene
    • C08L23/06Polyethene
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L23/00Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • C08L23/02Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
    • C08L23/10Homopolymers or copolymers of propene
    • C08L23/12Polypropene
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K2201/00Specific properties of additives
    • C08K2201/019Specific properties of additives the composition being defined by the absence of a certain additive

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

The present invention provides polyolefin compositions comprising i) a polyolefin, ii) one or more phosphorus-containing benzofuranone compounds and iii) one or more organophosphorus stabilizers, which compositions have excellent protection against discoloration and improved thermal stability during melt processing, which is manifested by improved molecular weight retention and retention of polymer molecular structure.

Description

Stabilized polyolefin compositions comprising benzofuranones and organophosphorus stabilizers
The present invention relates to polyolefin compositions comprising phosphorus-containing 3-phenyl-benzofuran-2-one compounds and specific organophosphorus stabilizers. The polyolefin compositions exhibit excellent color properties and improved thermal stability during melt processing.
For decades, traditional phenolic/phosphite antioxidant mixtures have been successfully used to provide good melt flow control and acceptable color retention properties to polyolefins. However, there is an increasing need to reduce the color of polyolefin articles and to improve color retention.
SUMMARY
Accordingly, disclosed herein are polyolefin compositions comprising i) a polyolefin, ii) one or more phosphorus-containing benzofuranone compounds, and iii) one or more organophosphorus stabilizers. The phosphorus-containing benzofuranone compounds can have the formula I-p1, I-p2, I-o1, I-o2, I-m1, or I-m2, as described in detail below. Also disclosed herein are additive compositions comprising a phosphorus-containing benzofuranone compound and an organophosphorus stabilizer.
Also disclosed herein is a method of stabilizing a polyolefin against the adverse effects of heat, light, and oxygen, which comprises incorporating into the polyolefin ii) one or more benzofuranone compounds selected from the group consisting of formula I-p1, I-p2, I-o1, I-o2, I-m1, and I-m2, and iii) one or more organophosphorus stabilizers. The adverse effects of heat, light and oxygen can lead to undesirable color.
Detailed description of the invention
The phosphorus-containing 3-phenyl-benzofuran-2-one compound may have the formula I-p1, I-p2, I-o1, I-o2, I-m1, or I-m2 (also referred to herein as a "benzofuran-2-one" or "benzofuranone" compound).
Figure BDA0002396795310000021
Figure BDA0002396795310000031
Wherein
X and Z are independently P or P ═ O; y isp、YoAnd YmIs oxygen or represents a covalent bond;
when Y isp、YoAnd YmWhen is oxygen, R1pRepresents one of the sub-formulae II-p, II-o or II-m:
Figure BDA0002396795310000032
Figure BDA0002396795310000041
R1orepresents one of the sub-formulae II-o or II-m, R1mRepresents the sub-formula II-m, or
R1pAnd R2pTogether, R1oAnd R2oTogether with R1mAnd R2mTogether represent one of the sub-formulae III, IV or V:
Figure BDA0002396795310000042
or R1p、R1oAnd R1mIs unsubstituted or substituted by C1-C8Alkyl radical, C1-C8Alkoxy, halogen or C substituted by one phenyl group6-C10Aryl radical, C1-C18Alkyl radical, C3-C16Cycloalkyl radical, C7-C13Aralkyl radical, C2-C18Alkenyl, C interrupted by one or more oxygen atoms2-C30Alkyl, or C interrupted by a sulfur atom2-C16Alkyl radical, R2pRepresents one of the sub-formulae II-p, II-o or II-m, R2oRepresents one of the sub-formulae II-o or II-m, R2mRepresents the sub-formula II-m, or R2pAnd R1pTogether, R2oAnd R1oTogether with R2mAnd R1mTogether represent one of the sub-formulae III, IV or V, or R2p、R2oAnd R2mIs unsubstituted or substituted by C1-C8Alkyl radical, C1-C8Alkoxy radicalHalogen or C substituted by one phenyl group6-C10Aryl radical, C1-C18Alkyl radical, C3-C16Cycloalkyl radical, C7-C13Aralkyl radical, C2-C18Alkenyl, C interrupted by one or more oxygen atoms2-C30Alkyl, or C interrupted by a sulfur atom2-C16An alkyl group; when Y isp、YoAnd YmWhen represents a covalent bond, R1pRepresents one of the sub-formulae II-p, II-o or II-m, R1oRepresents one of the sub-formulae II-o or II-m, R1mRepresents the sub-formula II-m, or R1p、R1oAnd R1mIs unsubstituted or substituted by C1-C8Alkyl radical, C1-C8Alkoxy, halogen or C substituted by one phenyl group6-C10Aryl radical, C1-C18Alkyl radical, C3-C16Cycloalkyl radical, C7-C13Aralkyl radical, C2-C18Alkenyl, C interrupted by one or more oxygen atoms2-C30Alkyl, or C interrupted by a sulfur atom2-C16Alkyl radical, R2p、R2oAnd R2mIs unsubstituted or substituted by C1-C8Alkyl radical, C1-C8Alkoxy, halogen or C substituted by one phenyl group6-C10Aryl, or halogen; r4、R5、R6And R7Each independently is hydrogen or C1-C8Alkyl radical, Rp2、Rp3、Rp5And Rp6Each independently is hydrogen or C1-C8Alkyl radical, Ro1、Ro2、Ro5And Ro6Each independently is hydrogen or C1-C8An alkyl group, a carboxyl group,
Rm1、Rm3、Rm5and Rm6Each independently is hydrogen or C1-C8Alkyl radical, Ra1、Ra2、Ra3And Ra4Each independently is hydrogen or C1-C8Alkyl radical, Rb1、Rb2、Rb3、Rb4、Rb5And Rb6Each independently is hydrogen or C1-C8Alkyl, and Rc1、Rc2、Rc3And Rc4Each independently is hydrogen or C1-C8An alkyl group.
A point of attachment on the subformulae II-p, II-o or II-m is indicated by the end of the line, which end has no property and is blank. The two connection points on subformulae III, IV or V are each represented by the ends of the respective lines, which have no characteristic and are blank. When R is1pAnd R2pTogether, R1oAnd R2oTogether with R1mAnd R2mWhen together represent one of the sub-formulae III, IV or V, R2pAnd R1pTogether, R2oAnd R1oTogether with R2mAnd R1mTogether represent the same sub-formula.
Compounds of the formulae I-p1, I-p2, I-o1, I-o2, I-m1 or 1-m2 have at least one asymmetric carbon atom, i.e. the carbon atom located in the 3-position of the benzofuran-2-one structural unit. Other asymmetric carbon atoms may be present in an alkyl substituent having at least four carbon atoms. Phosphorus atoms substituted with three different substituents may show steric inversion, which may result in an asymmetric phosphorus atom that is temperature dependent. The present invention relates to any of these enantiomers, resulting diastereomers, or mixtures thereof.
Unsubstituted or substituted by C1-C8Alkyl radical, C1-C8Alkoxy, halogen or C substituted by one phenyl group6-C10Aryl is for example phenyl, 2-methyl-phenyl, 3-methyl-phenyl, 4-methyl-phenyl, 2, 4-dimethyl-phenyl, 3, 5-dimethyl-phenyl, 4- (1, 1-dimethylethyl) -phenyl, 4- (1,1,3, 3-tetramethylpentyl) -phenyl, naphthalen-1-yl, naphthalen-2-yl, 6-methylnaphthalen-2-yl, 4-phenyl, 2-methoxy-phenyl, 3-methoxy-phenyl, 4-methoxy-phenyl, 2-ethoxyphenyl, 3-ethoxy-phenyl, 3- (n-propoxy) -phenyl, 4- (1, 1-dimethylethoxy) -phenyl, 2-chloro-phenyl, 3-chlorophenyl, 4-chlorophenyl, 2-chloro-4-methylphenyl. In some embodiments, C6-C10Aryl radicalsIs unsubstituted or substituted by C1-C8Alkyl or C1-C8Alkoxy substitution. In a particular embodiment, aryl is unsubstituted or substituted with C1-C8Alkyl-substituted phenyl. In other embodiments, aryl is phenyl.
C1-C8Alkyl is straight-chain or branched, and is, for example, methyl, ethyl, n-propyl, 1-methyl-ethyl, n-butyl, 1-methyl-propyl, 2-methyl-propyl, 1, 1-dimethyl-ethyl, n-pentyl, 1-methyl-butyl, 3-methyl-butyl, n-hexyl, 1-methyl-pentyl, 2-methyl-pentyl, 4-methyl-pentyl, 2-ethyl-butyl, n-heptyl, 1-methyl-hexyl, n-octyl, 1-methyl-heptyl, 2-ethyl-hexyl, 5, 5-dimethyl-hexyl or 1,1,3, 3-tetramethyl-butyl. In some embodiments, alkyl is C1-C4Alkyl or C8Alkyl, such as methyl, ethyl, 1-methyl-propyl, 1-dimethyl-ethyl or 1,1,3, 3-tetramethyl-butyl. In a particular embodiment, alkyl is C1-C4Alkyl groups such as methyl, ethyl, 1-methyl-propyl, 1-dimethyl-ethyl, and in other particular embodiments methyl, 1-methyl-propyl or 1, 1-dimethyl-ethyl.
C1-C8Alkoxy is straight-chain or branched and is, for example, methoxy, ethoxy, n-propoxy, 1-methyl-ethoxy, n-butoxy, 1-methyl-propoxy, 1, 1-dimethyl-ethoxy, n-pentoxy, 2-methyl-pentoxy, 2-ethyl-butoxy, 1-methyl-hexoxy, n-octoxy, 1-methyl-heptoxy, 2-ethyl-hexoxy, 1,1,3, 3-tetramethyl-butoxy. In some embodiments, alkoxy is C1-C4Alkoxy groups, such as methoxy.
Halogen is, for example, a fluorine atom (fluoro), a chlorine atom (chloro), a bromine atom (bromo) or an iodine atom (iodo). In particular embodiments, halogen is a chlorine atom or a fluorine atom; in some embodiments, the halogen is a fluorine atom.
C1-C18Alkyl being straight-chain or branched, e.g. methyl, ethyl, n-propyl, 1-methyl-ethylN-butyl, 1-methyl-propyl, 2-methyl-propyl, 1, 1-dimethyl-ethyl, n-pentyl, 1-methyl-butyl, 3-methyl-butyl, n-hexyl, 1-methyl-pentyl, 2-methyl-pentyl, 4-methyl-pentyl, 2-ethyl-butyl, n-heptyl, 1-methyl-hexyl, n-octyl, 1-methyl-heptyl, 2-ethyl-hexyl, 5, 5-dimethyl-hexyl, 1,1,3, 3-tetramethyl-butyl, n-nonyl, 2-ethyl-heptyl, n-decyl, undecyl, n-dodecyl, tridecyl, tetradecyl, pentadecyl, n-hexadecyl or n-octadecyl. In some embodiments, C1-C18Alkyl being straight-chain or branched C1-C12An alkyl group.
C3-C16Cycloalkyl being unsubstituted or substituted by C1-C4Alkyl substituents are, for example, cyclobutyl, cyclopentyl, 3, 4-dimethyl-cyclopentyl, cyclohexyl, 4-methyl-cyclohexyl, 4- (1-methylethyl) -cyclohexyl, 4- (1, 1-dimethylethyl) -cyclohexyl, 3, 5-dimethyl-cyclohexyl, 5-methyl-2- (1-methyl-ethyl) -cyclohexyl, cycloheptyl, cyclooctyl or cyclododecyl. In a particular embodiment, C3-C16Cycloalkyl is C5-C7Cycloalkyl radicals, such as cyclohexyl.
C7-C13Aralkyl is, for example, benzyl, 4-methyl-benzyl, 2-phenyl-ethyl, 3, 5-dimethylbenzyl, 1-phenyl-1, 1-dimethyl-methyl, 3-phenyl-propyl, 3-phenyl-2-methyl-propyl, 3, 5-di-tert-butyl-benzyl or 4-phenyl-methyl. In a particular embodiment, the aralkyl group is benzyl. C2-C18Alkenyl is straight-chain or branched, for example vinyl, allyl, Z-or E-but-2-en-yl, or E-but-3-en-yl, Z-or E-pent-2-en-yl, pent-4-en-yl, Z-or E-2-methyl-but-2-en-yl, Z-or E-3-methyl-but-3-en-yl, Z-or E-hex-1-en-yl, Z-or E-hexadec-9-en-yl or Z-or E-octadec-9-en-yl, (9Z,12Z) -octadeca-9, 12-dienyl or (9Z,12Z,15Z) -octadeca-9, 12, 15-triene-yl. In a particular embodiment, alkenyl is allyl.
C interrupted by one or more oxygen atoms2-C30The alkyl group is either straight-chain or branched,examples are methoxy-methyl, 2-methoxy-ethyl, 2-ethoxy-ethyl, 2- (2-methoxy-ethoxy) -ethyl, 2-n-butoxy-ethyl, 2- [2- (2-methoxy-ethoxy) -ethoxy]-ethyl, 2- [2- [2- (2-methoxy-ethoxy) -ethoxy ] -ethyl]-ethoxy radical]-ethyl, 2- (2-methoxy-1-methyl-ethoxy) -1-methyl-ethyl, 3- (n-propoxy) -propyl, 2- [2- [2- (2-n-butoxy-ethoxy) -ethoxy ] -ethoxy]-ethoxy radical]-ethyl, 2- [2- (2-n-butoxy-2-methyl-ethoxy) -2-methyl-ethoxy]-2-methyl-ethyl or 2- [ (2-n-lauryl) -ethoxy]-ethyl. In some embodiments, the alkyl group interrupted by one or more oxygen atoms is a 2-methoxy-ethyl or 2-ethoxy-ethyl group.
C interrupted by a sulfur atom2-C16Alkyl is straight-chain or branched, and is, for example, 2- (methyl-sulfanyl) -ethyl, 3-thiaundecyl or 3-thiapentadecyl.
In some embodiments, the benzofuranone is a compound of formula I-p1, I-p2, I-o1, I-o2, I-m1, or I-m2, wherein R4And R6Is hydrogen, and R5And R7Each independently is hydrogen or C1-C8Alkyl radicals, e.g. hydrogen or C1-C4An alkyl group. In certain embodiments, R4、R6And R7Is hydrogen, and R5Is hydrogen or C1-C8Alkyl radicals, e.g. hydrogen or C1-C4An alkyl group. In some embodiments, Rp2And Rp6Each independently is hydrogen or C1Alkyl radical, Rp3And Rp5Each independently is hydrogen or C1-C4Alkyl radical, Ro1And Ro6Each independently is hydrogen or C1-C8Alkyl radical, Ro2Is hydrogen or C1Alkyl, and Ro5Is hydrogen or C1-C4Alkyl radical, Rm1Is hydrogen or C1Alkyl radical, Rm3And Rm5Each independently is hydrogen or C1-C4Alkyl, and Rm6Is hydrogen or C1-C8An alkyl group.
In particular embodiments, the benzofuranones are of the formula I-p1, I-p2, I-o1, I-o2, I-m1 or I-m2, wherein Rp2And Rp6Is hydrogen, and Rp3And Rp5Each independently is hydrogen or C1-C4Alkyl radical, Ro1Is hydrogen or C1-C8Alkyl radical, Ro2Is hydrogen, Ro5And Ro6Each independently is hydrogen or C1-C4Alkyl radical, Rm1And Rm3Is hydrogen or C1Alkyl radical, Rm5Is hydrogen or C1-C3Alkyl, and Rm6Is hydrogen or C1-C8An alkyl group. In other embodiments, Rp2And Rp6Is hydrogen, and Rp3And Rp5Each independently is hydrogen or C1-C4Alkyl radical, wherein Rp3And Rp5One is not C4Alkyl radical, Ro1Is hydrogen or C1-C8Alkyl radical, Ro2Is hydrogen, Ro5Is hydrogen or C1-C3Alkyl, and
Ro6is hydrogen or C1-C4Alkyl, and Rm1And Rm3Is hydrogen or C1Alkyl radical, Rm5Is hydrogen or C1-C3Alkyl, and Rm6Is hydrogen or C1-C8An alkyl group.
In some embodiments, Rp2And Rp6Is hydrogen, and Rp3And Rp5One being hydrogen and the other being hydrogen or C1-C4Alkyl radical, Ro1Is hydrogen or C1-C8Alkyl radical, Ro2Is hydrogen, Ro5Is hydrogen or C1Alkyl radical, Ro6Is hydrogen or C1-C4Alkyl radical, Rm1、Rm3And Rm5Is hydrogen, and Rm6Is hydrogen or C1-C8An alkyl group. In certain embodiments, Ra1、Ra2、Ra3And Ra4Each independently is hydrogen or C1-C4Alkyl radical, Rb1、Rb2、Rb3、Rb4、Rb5And Rb6Each independently is hydrogen or C1-C4Alkyl, and Rc1、Rc2、Rc3And Rc4Each independently is hydrogen or C1-C4An alkyl group.
In some embodiments, Ra1、Ra2、Ra3And Ra4Each independently is hydrogen or C1-C4Alkyl radical, Rb1、Rb2、Rb3、Rb4Each independently is hydrogen or C1-C4Alkyl, and Rb5And Rb6One is C1-C4Alkyl, and the other is hydrogen, and Rc1、Rc2、Rc3And Rc4Each independently is hydrogen or C1-C4An alkyl group. In particular embodiments, Yp、YoAnd YmIs oxygen or represents a covalent bond; when Y isp、YoAnd YmWhen is oxygen, R1pRepresents one of the sub-formulae II-p, II-o or II-m, R1oRepresents one of the sub-formulae II-o or II-m, R1mRepresents the sub-formula II-m, or R1pAnd R2pTogether, R1oAnd R2oTogether with R1mAnd R2mTogether represent one of the sub-formulae III, IV or V, or R1p、R1oAnd R1mIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C10Aryl radical, C1-C18Alkyl radical, C3-C16Cycloalkyl radicals, or C2-C18Alkenyl radical, R2pRepresents one of the sub-formulae II-p, II-o or II-m, R2oRepresents one of the sub-formulae II-o or II-m, R2mRepresents the sub-formula II-m, or R2pAnd R1pTogether, R2oAnd R1oTogether with R2mAnd R1mTogether represent one of the sub-formulae III, IV or V, or R2p、R2oAnd R2mIs unsubstituted or substituted by C1-C6Alkyl substituted C6-C10Aryl radical, C1-C18Alkyl radical, C3-C16Cycloalkyl radicals, or C2-C18An alkenyl group; when Y isp、YoAnd YmWhen represents a covalent bond, R1pIs represented by the sub-formula IIOne of-p, II-o or II-m, R1oRepresents one of the sub-formulae II-o or II-m, R1mRepresents the sub-formula II-m, or R1p、R1oAnd R1mIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C12Aryl radical, C1-C18Alkyl radical, C3-C16Cycloalkyl radicals, or C2-C18Alkenyl, and R2p、R2oAnd R2mIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C10Aryl, or halogen, wherein halogen is chloro or fluoro.
In some embodiments, Y isp、YoAnd YmIs oxygen or represents a covalent bond; when Y isp、YoAnd YmWhen is oxygen, R1pRepresents the sub-formula II-p, R1oRepresents formula II-o, R1mRepresents the sub-formula II-m, or R1pAnd R2pTogether, R1oAnd R2oTogether with R1mAnd R2mTogether represent one of the sub-formulae III, IV or V, or R1p、R1oAnd R1mIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C10Aryl radical, C1-C18Alkyl radical, C3-C16Cycloalkyl radicals, or C2-C18Alkenyl, and R2pRepresents the sub-formula II-p, R2oRepresents the sub-formula II-o, R2mRepresents the sub-formula II-m, or R2pAnd R1pTogether, R2oAnd R1oTogether with R2mAnd R1mTogether represent one of the sub-formulae III, IV or V, or R2p、R2oAnd R2mIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C10Aryl radical, C1-C18Alkyl radical, C3-C16Cycloalkyl radicals, or C2-C18An alkenyl group; when Y isp、YoAnd YmWhen represents a covalent bond, R1pRepresents the sub-formula II-p, R1oRepresents the sub-formula II-o, R1mRepresents the sub-formula II-m, or R1p、R1oAnd R1mIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C10Aryl radical, C1-C18Alkyl radical, C3-C16Cycloalkyl radicals, or C2-C18Alkenyl, and R2p、R2oAnd R2mIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C10Aryl, or halogen, wherein halogen is chloro or fluoro.
In some embodiments, the benzofuranone is a compound of formula I-p1, I-p2, I-o1, I-o2, I-m1, or I-m2, wherein Y isp、YoAnd YmIs oxygen or represents a covalent bond; when Y isp、YoAnd YmWhen is oxygen, R1pRepresents the sub-formula II-p, R1oRepresents formula II-o, R1mRepresents the sub-formula II-m, or R1pAnd R2pTogether, R1oAnd R2oTogether with R1mAnd R2mTogether represent one of the sub-formulae III, IV or V, or R1p、R1oAnd R1mIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C10Aryl radical, C1-C18Alkyl radical, C3-C16Cycloalkyl radicals, or C2-C18Alkenyl, and R2pIs R1p,R2oIs R1o,R2mIs R1mOr R is2pAnd R1pTogether, R2oAnd R1oTogether with R2mAnd R1mTogether represent one of the sub-formulae III, IV or V; when Y isp、YoAnd YmWhen represents a covalent bond, R1pRepresents the sub-formula II-p, R1oRepresents the sub-formula II-o, R1mRepresents the sub-formula II-m, and R2p、R2oAnd R2mIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C10Aryl, or halogen, wherein halogen is chloro or fluoro.
In some embodiments, the benzofuranone is a compound of formula I-p1, I-p2, I-o1, I-o2, I-m1, or I-m2, wherein Y isp、YoAnd YmIs oxygenOr represents a covalent bond; when Y isp、YoAnd YmWhen is oxygen, R1pRepresents one of the sub-formulae II-p, II-o or II-m, R1oRepresents one of the sub-formulae II-o or II-m, R1mRepresents the sub-formula II-m, or R1pAnd R2pTogether, R1oAnd R2oTogether with R1mAnd R2mTogether represent one of the sub-formulae III, IV or V, or R1p、R1oAnd R1mIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C10Aryl radical, C1-C18Alkyl, or C3-C16Cycloalkyl radical, and R2pRepresents one of the sub-formulae II-p, II-o or II-m, R2oRepresents one of the sub-formulae II-o or II-m, R2mRepresents the sub-formula II-m, or R2pAnd R1pTogether, R2oAnd R1oTogether with R2mAnd R1mTogether represent one of the sub-formulae III, IV or V, or R2p、R2oAnd R2mIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C10Aryl radical, C1-C18Alkyl or C3-C16A cycloalkyl group; when Y isp、YoAnd YmWhen represents a covalent bond, R1pRepresents one of the sub-formulae II-p, II-o or II-m, R1oRepresents one of the sub-formulae II-o or II-m, R1mRepresents the sub-formula II-m, or R1p、R1oAnd R1mIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C10Aryl radical, C1-C18Alkyl, or C3-C16Cycloalkyl radical, and R2p、R2oAnd R2mIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C10Aryl, or fluoro.
In particular embodiments, Yp、YoAnd YmIs oxygen or represents a covalent bond; when Y isp、YoAnd YmWhen is oxygen, R1pRepresents one of the sub-formulae II-p, II-o or II-m, R1oRepresents one of the sub-formulae II-o or II-m, R1mRepresents a compound of the sub-formula II-m,or R1pAnd R2pTogether, R1oAnd R2oTogether with R1mAnd R2mTogether represent sub-formula III, or R1p、R1oAnd R1mIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C10Aryl, or C1-C18Alkyl, and R2pRepresents one of the sub-formulae II-p, II-o or II-m, R2oRepresents one of the sub-formulae II-o or II-m, R2mRepresents the sub-formula II-m, or R2pAnd R1pTogether, R2oAnd R1oTogether with R2mAnd R1mTogether represent sub-formula III, or R2p、R2oAnd R2mIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C10Aryl, or C1-C18An alkyl group; when Y isp、YoAnd YmWhen represents a covalent bond, R1pRepresents one of the sub-formulae II-p, II-o or II-m, R1oRepresents one of the sub-formulae II-o or II-m, R1mRepresents the sub-formula II-m, or R1p、R1oAnd R1mIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C10Aryl, or C1-C18Alkyl, and R2p、R2oAnd R2mIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C10Aryl, or fluoro.
In some embodiments, the benzofuranone is a compound of formula I-p1, I-p2, I-o1, or I-o2, wherein Y ispAnd YoIs oxygen or represents a covalent bond; when Y ispAnd YoWhen is oxygen, R1p、R2p、R1oOr R2oDoes not represent sub-formula II-m; when Y ispAnd YoWhen represents a covalent bond, R1pOr R1oDoes not represent sub-formula II-m. In certain embodiments, in the compounds of formula I-p1 or I-p2, Y ispIs oxygen or represents a covalent bond; when Y ispWhen is oxygen, R1pOr R2pDoes not represent sub-formula II-o or II-m; when Y ispWhen represents a covalent bond, R1pDo not represent sub-formula II-o orII-m。
In some embodiments, the benzofuranone is a compound of formula I-p1, I-p2, I-o1, I-o2, I-m1, or I-m2, wherein Y isp、YoAnd YmIs oxygen or represents a covalent bond; when Y isp、YoAnd YmWhen is oxygen, R1pRepresents one of the sub-formulae II-p, II-o or II-m, R1oRepresents one of the sub-formulae II-o or II-m, R1mRepresents the sub-formula II-m, or R1p、R1oAnd R1mIs unsubstituted or substituted by C1-C8Alkyl radical, C1-C8Alkoxy, halogen or C substituted by one phenyl group6-C10Aryl radical, C1-C18Alkyl radical, C3-C16Cycloalkyl radical, C7-C13Aralkyl radical, C2-C18Alkenyl, C interrupted by one or more oxygen atoms2-C30Alkyl, or C interrupted by a sulfur atom2-C16An alkyl group; r2pRepresents one of the sub-formulae II-p, II-o or II-m, R2oRepresents one of the sub-formulae II-o or II-m, R2mRepresents the sub-formula II-m, or R2p、R2oAnd R2mIs unsubstituted or substituted by C1-C8Alkyl radical, C1-C8Alkoxy, halogen or C substituted by one phenyl group6-C10Aryl radical, C1-C18Alkyl radical, C3-C16Cycloalkyl radical, C7-C13Aralkyl radical, C2-C18Alkenyl, C interrupted by one or more oxygen atoms2-C30Alkyl, or C interrupted by a sulfur atom2-C16An alkyl group; when Y isp、YoAnd YmWhen represents a covalent bond, R1pRepresents one of the sub-formulae II-p, II-o or II-m, R1oRepresents one of the sub-formulae II-o or II-m, R1mRepresents the sub-formula II-m, or R1p、R1oAnd R1mIs unsubstituted or substituted by C1-C8Alkyl radical, C1-C8Alkoxy, halogen or C substituted by one phenyl group6-C10Aryl radical, C1-C18Alkyl radical, C3-C16Cycloalkyl radical, C7-C13Aralkyl radical, C2-C18Alkenyl, C interrupted by one or more oxygen atoms2-C30Alkyl, or C interrupted by a sulfur atom2-C16An alkyl group; r2p、R2oAnd R2mIs unsubstituted or substituted by C1-C8Alkyl radical, C1-C8Alkoxy, halogen or C substituted by one phenyl group6-C10Aryl, or halogen.
In particular embodiments, the benzofuranone is a compound of formula I-p1, I-p2, I-o1, I-o2, I-m1, or I-m2, wherein Y isp、YoAnd YmIs oxygen. In some embodiments, the benzofuranone is a compound of formula I-p or I-o, wherein Y ispAnd YoIs oxygen, and R1p、R2p、R1oOr R2oDoes not represent sub-formula II-m. In other embodiments, the benzofuranone is a compound of formula I-p1, I-p2, I-o1, I-o2, I-m1, or I-m2, wherein Y isp、YoAnd YmIs oxygen, R1pAnd R2pTogether, R1oAnd R2oTogether with R1mAnd R2mTogether represent one of the sub-formulae III, IV or V, and R2pAnd R1pTogether, R2oAnd R1oTogether with R2mAnd R1mTogether represent one of the sub-formulae III, IV or V.
In some embodiments, the benzofuranone is a compound of formula I-p1, I-p2, I-o1, or I-o2, wherein Y ispAnd YoIs oxygen, R1pAnd R2pTogether with R1oAnd R2oTogether represent one of the sub-formulae III, IV or V, and R2pAnd R1pTogether with R2oAnd R1oTogether represent one of the sub-formulae III, IV or V. In certain embodiments, the benzofuranone is a compound of formula I-p1 or I-p2, wherein Yp is oxygen, and R is1pAnd R2pTogether represent one of the sub-formulae III, IV or V. In some embodiments, the benzofuranone is a compound of formula I-p, wherein Yp is oxygen, and R is1pAnd R2pTogether represent sub-formula IV.
The above embodiments for compounds of the formulae I-p1, I-p2, I-o1, I-o2, I-m1 or I-m2 each represent a structural unit having the formula I-p1, I-p2, I-o1, I-o2, I-m1 or I-m 2. These structural units comprise benzofuran-2-one units including R4、R5、R6And R7(ii) a A phenylene linking unit comprising Rp2、Rp3、Rp5、Rp6、Ro1、Ro2、Ro5、Ro6、Rm1、Rm3、Rm5And Rm6(ii) a And other units adjacent to the phosphorus atom comprising R1p、R2p、R1o、R2o、R1mAnd R2mHaving substituents of sub-formula III, IV or V, i.e. Ra1、Ra1、Ra3、Ra4、Rb1、Rb2、Rb3、Rb4、Rb5、Rb6、Rc1、Rc2、Rc3And Rc4. The above-described embodiments with respect to these three building blocks can be combined. Examples of which are described below.
In some embodiments, the benzofuranone is a compound of formula I-p1, I-p2, I-o1, I-o2, I-m1, or I-m2, wherein Y isp、YoAnd YmIs oxygen or represents a covalent bond; when Y isp、YoAnd YmWhen is oxygen, R1pRepresents one of the sub-formulae II-p, II-o or II-m, R1oRepresents one of the sub-formulae II-o or II-m, R1mRepresents the sub-formula II-m, or R1pAnd R2pTogether, R1oAnd R2oTogether with R1mAnd R2mTogether represent one of the sub-formulae III, IV or V, or R1p、R1oAnd R1mIs unsubstituted or substituted by C1-C8Alkyl radical, C1-C8Alkoxy, halogen or C substituted by one phenyl group6-C10Aryl radical, C1-C18Alkyl radical, C3-C16Cycloalkyl radical, C7-C13Aralkyl radical, C2-C18Alkenyl radicals bound by one or more oxygen atomsSpaced C2-C30Alkyl, or C interrupted by a sulfur atom2-C16Alkyl radical, R2pRepresents one of the sub-formulae II-p, II-o or II-m, R2oRepresents one of the sub-formulae II-o or II-m, R2mRepresents the sub-formula II-m, or R2pAnd R1pTogether, R2oAnd R1oTogether with R2mAnd R1mTogether represent one of the sub-formulae III, IV or V, or R2p、R2oAnd R2mIs unsubstituted or substituted by C1-C8Alkyl radical, C1-C8Alkoxy, halogen or C substituted by one phenyl group6-C10Aryl radical, C1-C18Alkyl radical, C3-C16Cycloalkyl radical, C7-C13Aralkyl radical, C2-C18Alkenyl, C interrupted by one or more oxygen atoms2-C30Alkyl, or C interrupted by a sulfur atom2-C16An alkyl group; when Y isp、YoAnd YmWhen represents a covalent bond, R1pRepresents one of the sub-formulae II-p, II-o or II-m, R1oRepresents one of the sub-formulae II-o or II-m, R1mRepresents the sub-formula II-m, or R1p、R1oAnd R1mIs unsubstituted or substituted by C1-C8Alkyl radical, C1-C8Alkoxy, halogen or C substituted by one phenyl group6-C10Aryl radical, C1-C18Alkyl radical, C3-C16Cycloalkyl radical, C7-C13Aralkyl radical, C2-C18Alkenyl, C interrupted by one or more oxygen atoms2-C30Alkyl, or C interrupted by a sulfur atom2-C16Alkyl radical, R2p、R2oAnd R2mIs unsubstituted or substituted by C1-C8Alkyl radical, C1-C8Alkoxy, halogen or C substituted by one phenyl group6-C10Aryl, or halogen; r4And R6Is hydrogen, R5And R7Each independently is hydrogen or C1-C8Alkyl radical, Rp2And Rp6Each independently is hydrogen or C1Alkyl radical, Rp3And Rp5Each independently is hydrogen or C1-C4Alkyl radical, Ro1And Ro6Each independently is hydrogen or C1-C8Alkyl radical, Ro2Is hydrogen or C1Alkyl radical, Ro5Is hydrogen or C1-C4Alkyl radical, Rm1Is hydrogen or C1Alkyl radical, Rm3And Rm5Each independently is hydrogen or C1-C4Alkyl radical, Rm6Is hydrogen or C1-C8Alkyl radical, Ra1、Ra2、Ra3And Ra4Each independently is hydrogen or C1-C4Alkyl radical, Rb1、Rb2、Rb3、Rb4、Rb5And Rb6Each independently is hydrogen or C1-C4Alkyl, and Rc1、Rc2、Rc3And Rc4Each independently is hydrogen or C1-C4An alkyl group.
In some embodiments, the benzofuranone is a compound of formula I-p1, I-p2, I-o1, I-o2, I-m1, or I-m2, wherein Y isp、YoAnd YmIs oxygen or represents a covalent bond; when Y isp、YoAnd YmWhen is oxygen, R1pRepresents one of the sub-formulae II-p, II-o or II-m, R1oRepresents one of the sub-formulae II-o or II-m, R1mRepresents the sub-formula II-m, or R1pAnd R2pTogether, R1oAnd R2oTogether with R1mAnd R2mTogether represent one of the sub-formulae III, IV or V, or R1p、R1oAnd R1mIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C10Aryl radical, C1-C18Alkyl, or C3-C16Cycloalkyl radical, and R2pRepresents one of the sub-formulae II-p, II-o or II-m, R2oRepresents one of the sub-formulae II-o or II-m, R2mRepresents the sub-formula II-m, or R2pAnd R1pTogether, R2oAnd R1oTogether with R2mAnd R1mTogether represent one of the sub-formulae III, IV or V, or R2p、R2oAnd R2mIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C10Aryl radical, C1-C18Alkyl or C3-C16A cycloalkyl group; when Y isp、YoAnd YmWhen represents a covalent bond, R1pRepresents one of the sub-formulae II-p, II-o or II-m, R1oRepresents one of the sub-formulae II-o or II-m, R1mRepresents the sub-formula II-m, or R1p、R1oAnd R1mIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C10Aryl radical, C1-C18Alkyl or C3-C16Cycloalkyl radical, and R2p、R2oAnd R2mIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C10Aryl, or fluoro; r4、R5、R6And R7Each independently is hydrogen or C1-C8Alkyl radical, Rp2、Rp3、Rp5And Rp6Each independently is hydrogen or C1-C8Alkyl radical, Ro1、Ro2、Ro5And Ro6Each independently is hydrogen or C1-C8Alkyl radical, Rm1、Rm3、Rm5And Rm6Each independently is hydrogen or C1-C8Alkyl radical, Ra1、Ra2、Ra3And Ra4Each independently is hydrogen or C1-C8Alkyl radical, Rb1、Rb2、Rb3、Rb4、Rb5And Rb6Each independently is hydrogen or C1-C8Alkyl, and Ro1、Rc2、Rc3And Rc4Each independently is hydrogen or C1-C8An alkyl group.
In particular embodiments, the benzofuranone is a compound of formula I-p1, I-p2, I-o1, or I-o2, wherein Y ispAnd YoIs oxygen or represents a covalent bond; when Y ispAnd YoWhen is oxygen, R1pRepresents one of the sub-formulae II-p or II-o, R1oRepresents the sub-formula II-o, or R1pAnd R2pTogether with R1oAnd R2oTogether represent one of the sub-formulae III, IV or V, or R1pAnd R1oIs unsubstituted or substituted by C1-C8Alkyl radical, C1-C8Alkoxy, halogen or C substituted by one phenyl group6-C10Aryl radical, C1-C18Alkyl radical, C3-C16Cycloalkyl radical, C7-C13Aralkyl radical, C2-C18Alkenyl, C interrupted by one or more oxygen atoms2-C30Alkyl, or C interrupted by a sulfur atom2-C16Alkyl radical, R2pRepresents one of the sub-formulae II-p or 11-0, R2oRepresents the sub-formula II-o, or R2pAnd R1pTogether with R2oAnd R1oTogether represent one of the sub-formulae III, IV or V, or R2pAnd R2oIs unsubstituted or substituted by C1-C8Alkyl radical, C1-C8Alkoxy, halogen or C substituted by one phenyl group6-C10Aryl radical, C1-C18Alkyl radical, C3-C16Cycloalkyl radical, C7-C13Aralkyl radical, C2-C18Alkenyl, C interrupted by one or more oxygen atoms2-C30Alkyl, or C interrupted by a sulfur atom2-C16An alkyl group; when Y ispAnd YoWhen represents a covalent bond, R1pRepresents one of the sub-formulae II-p or II-o, R1oRepresents the sub-formula II-o, or R1pAnd R1oIs unsubstituted or substituted by C1-C8Alkyl radical, C1-C8Alkoxy, halogen or C substituted by one phenyl group6-C10Aryl radical, C1-C18Alkyl radical, C3-C16Cycloalkyl radical, C7-C13Aralkyl radical, C2-C18Alkenyl, C interrupted by one or more oxygen atoms2-C30Alkyl, or C interrupted by a sulfur atom2-C16Alkyl radical, R2pAnd R2oIs unsubstituted or substituted by C1-C8Alkyl radical, C1-C6Alkoxy, halogen or C substituted by one phenyl group6-C10Aryl, or halogen; r4、R5、R6And R7Each independently is hydrogen or C1-C6Alkyl radical, Rp2、Rp3、Rp5And Rp6Each independently is hydrogen or C1-C8Alkyl radical, Ro1、Ro2、Ro5And Ro6Each independently is hydrogen or C1-C8Alkyl radical, Ra1、Ra2、Ra3And Ra4Each independently is hydrogen or C1-C8Alkyl radical, Rb1、Rb2、Rb3、Rb4、Rb5And Rb6Each independently is hydrogen or C1-C8Alkyl, and Rc1、Rc2、Rc3And Rc4Each independently is hydrogen or C1-C8An alkyl group.
In some embodiments, the benzofuranone is a compound of formula I-p1, I-p2, I-o1, or I-o2, wherein Y ispAnd YoIs oxygen or represents a covalent bond; when Y ispAnd YoWhen is oxygen, R1pRepresents one of the sub-formulae II-p or II-o, R1oRepresents the sub-formula II-o, or R1pAnd R2pTogether with R1oAnd R2oTogether represent sub-formula III, or R1pAnd R1oIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C10Aryl, or C1-C18Alkyl radical, R2pRepresents one of the sub-formulae II-p or II-o, R2oRepresents the sub-formula II-o, or R2pAnd R1pTogether with R2oAnd R1oTogether represent sub-formula III, or R2pAnd R2oIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C10Aryl, or C1-C18An alkyl group; when Y ispAnd YoWhen represents a covalent bond, R1pRepresents one of the sub-formulae II-p or II-o, R1oRepresents the sub-formula II-o, or R1pAnd R1oIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C10Aryl, or C1-C18Alkyl radical, R2pAnd R2oIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C10Aryl, or fluoro; r4And R6Is hydrogen, R5And R7Each independently is hydrogen or C1-C8Alkyl radical, Rp2And Rp6Is hydrogen, Rp3And Rp5Each independently is hydrogen or C1-C4Alkyl radical, wherein Rp3And Rp5One is not CaAlkyl radical, Ro1Is hydrogen or C1-C8Alkyl radical, Ro2Is hydrogen, Ro5Is hydrogen or C1-C3Alkyl radical, Ro6Is hydrogen or C1-C4Alkyl radical, Ra1、Rae、Ra3And Ra4Each independently is hydrogen or C1-C4Alkyl radical, Rb1、Rb2、Rb3、Rb4、Rb5And Rb6Each independently is hydrogen or C1-C4Alkyl, and Rc1、Rc2、Rc3And Rc4Each independently is hydrogen or C1-C4An alkyl group.
In other embodiments, the benzofuranone is a compound of formula I-p1, I-p2, I-o1, I-o2, I-m1, or I-m2, wherein Y isp、YoAnd YmIs oxygen or represents a covalent bond; when Y isp、YoAnd YmWhen is oxygen, R1pRepresents one of the sub-formulae II-p, II-o or II-m, R1oRepresents one of the sub-formulae II-o or II-m, R1mRepresents the sub-formula II-m, or R1p、R1oAnd R1mIs unsubstituted or substituted by C1-C8Alkyl radical, C1-C8Alkoxy, halogen or C substituted by one phenyl group6-C10Aryl radical, C1-C18Alkyl radical, C3-C16Cycloalkyl radical, C7-C13Aralkyl radical, C2-C18Alkenyl, C interrupted by one or more oxygen atoms2-C30Alkyl, or C interrupted by a sulfur atom2-C16Alkyl radical, R2pRepresents the sub-formulae II-p, IIOne of-o or II-m, R2oRepresents one of the sub-formulae II-o or II-m, R2mRepresents the sub-formula II-m, or R2p、R2oAnd R2mIs unsubstituted or substituted by C1-C8Alkyl radical, C1-C8Alkoxy, halogen or C substituted by one phenyl group6-C10Aryl radical, C1-C18Alkyl radical, C3-C16Cycloalkyl radical, C7-C13Aralkyl radical, C2-C18Alkenyl, C interrupted by one or more oxygen atoms2-C30Alkyl, or C interrupted by a sulfur atom2-C16An alkyl group; when Y isp、YoAnd YmWhen represents a covalent bond, R1pRepresents one of the sub-formulae II-p, II-o or II-m, R1oRepresents one of the sub-formulae II-o or II-m, R1mRepresents the sub-formula II-m, or R1p、R1oAnd R1mIs unsubstituted or substituted by C1-C8Alkyl radical, C1-C8Alkoxy, halogen or C substituted by one phenyl group6-C10Aryl radical, C1-C18Alkyl radical, C3-C16Cycloalkyl radical, C7-C13Aralkyl radical, C2-C18Alkenyl, C interrupted by one or more oxygen atoms2-C30Alkyl, or C interrupted by a sulfur atom2-C16Alkyl radical, R2p、R2oAnd R2mIs unsubstituted or substituted by C1-C8Alkyl radical, C1-C8Alkoxy, halogen or C substituted by one phenyl group6-C10Aryl, or halogen; r4、R5、R6And R7Each independently is hydrogen or C1-C8Alkyl radical, Rp2、Rp3、Rp5And Rp6Each independently is hydrogen or C1-C8Alkyl radical, Ro1、Ro2、Ro5And Ro6Each independently is hydrogen or C1-C8Alkyl, and Rm1、Rm3、Rm5And Rm6Each independently is hydrogen or C1-C8An alkyl group.
In some embodiments, the benzofuranone is a compound of formula I-p1, I-p2, I-o1, I-o2, I-m1, or I-m2, wherein Y isp、YoAnd YmIs oxygen, R1pAnd R2pTogether, R1oAnd R2oTogether with R1mAnd R2mTogether represent one of the sub-formulae III, IV or V, R2pAnd R1pTogether, R2oAnd R1oTogether with R2mAnd R1mTogether represent one of the sub-formulae III, IV or V, R4、R5、R6And R7Each independently is hydrogen or C1-C8Alkyl radical, Rp2、Rp3、Rp5And Rp6Each independently is hydrogen or C1-C8Alkyl radical, Ro1、Ro2、Ro5And Ro6Each independently is hydrogen or C1-C8Alkyl radical, Rm1、Rm3、Rm5And Rm6Each independently is hydrogen or C1-C8Alkyl radical, Ra1、Ra2、Ra3And Ra4Each independently is hydrogen or C1-C8Alkyl radical, Rb1、Rb2、Rb3、Rb4、Rb5And Rb6Each independently is hydrogen or C1-C8Alkyl, and Rc1、Rc2、Rc3And Rc4Each independently is hydrogen or C1-C8An alkyl group.
In particular embodiments, the benzofuranone is a compound of formula I-p1, I-p2, I-o1, or I-o2, wherein Y ispAnd YoIs oxygen, R1pAnd R2pTogether with R1oAnd R2oTogether represent one of the sub-formulae III, IV or V, R2pAnd R1pTogether with R2oAnd R1oTogether represent one of the sub-formulae III, IV or V, R4、R5、R6And R7Each independently is hydrogen or C1-C8Alkyl radical, Rp2、Rp3、Rp5And Rp6Each independently is hydrogen or C1-C8Alkyl radical,Ro1、Ro2、Ro5And Ro6Each independently is hydrogen or C1-C8Alkyl radical, Ra1、Ra2、Ra3And Ra4Each independently is hydrogen or C1-C8Alkyl radical, Rb1、Rb2、Rb3、Rb4、Rb5And Rb6Each independently is hydrogen or C1-C8Alkyl, and Rc1、Rc2、Rc3And Rc4Each independently is hydrogen or C1-C8An alkyl group.
In some embodiments, the benzofuranone is a compound of formula I-p1 or I-p2, wherein Y ispIs oxygen, R1pAnd R2pTogether represent one of the sub-formulae III, IV or V, R4、R5、R6And R7Each independently is hydrogen or C1-C8Alkyl radical, Rp2、Rp3、Rp5And Rp6Each independently is hydrogen or C1-C8Alkyl radical, Ra1、Ra2、Ra3And Ra4Each independently is hydrogen or C1-C8Alkyl radical, Rb1、Rb2、Rb3、Rb4、Rb5And Rb6Each independently is hydrogen or C1-C8Alkyl, and Rc1、Rc2、Rc3And Rc4Each independently is hydrogen or C1-C8An alkyl group.
In some embodiments, in the benzofuranone compounds of formula I-p1 or I-p2, Y ispIs oxygen, R1pAnd R2pTogether represent sub-formula IV, R4、R5、R6And R7Each independently is hydrogen or C1-C8Alkyl radical, Rp2、Rp3、Rp5And Rp6Each independently is hydrogen or C1-C8Alkyl, and Rb1、Rb2、Rb3、Rb4、Rb5And Rb6Each independently is hydrogen or C1-C8An alkyl group.
In some embodiments, the benzofuranone is a compound selected from formulas (101) to (133):
Figure BDA0002396795310000171
Figure BDA0002396795310000181
Figure BDA0002396795310000191
Figure BDA0002396795310000201
Figure BDA0002396795310000211
Figure BDA0002396795310000221
Figure BDA0002396795310000231
Figure BDA0002396795310000241
Figure BDA0002396795310000251
Figure BDA0002396795310000261
Figure BDA0002396795310000271
Figure BDA0002396795310000281
Figure BDA0002396795310000291
benzofuranones of the invention can be prepared as described in US2017/0226323, US2017/0066905 and US application No.15/751497, published as WO 2017/025431.
Organic phosphorus stabilizers include organic phosphite and organic phosphonite stabilizers, including for example triphenyl phosphite, diphenylalkyl phosphites, phenyl dialkyl phosphites, tris (nonylphenyl) phosphite, trilauryl phosphite, trioctadecyl phosphite, tris (2, 4-di-tert-butylphenyl) phosphite, tris- (2-sec-butylphenyl) phosphite (O), distearyl pentaerythritol diphosphite (F), bis (2, 4-di- α -cumylphenyl) pentaerythritol diphosphite (K), diisodecyl pentaerythritol diphosphite, bis (2, 4-di-tert-butylphenyl) pentaerythritol diphosphite (D), bis (2, 6-di-tert-butyl-4-methylphenyl) pentaerythritol diphosphite (E), diisodecyloxy-pentaerythritol diphosphite, bis (2, 4-di-tert-butyl-6-methylphenyl) pentaerythritol diphosphite, bis (2,4, 6-tri-tert-butylphenyl) pentaerythritol diphosphite, tristearyl sorbitol triphosphite, tetrakis (2, 4-di-tert-butylphenyl) 4,4' -dioctadene-biphenyl-8, 8-tetra-tert-butyl-O-diphenyl phosphite, dibenzo [4, 8-tert-butyl-4-diphenyl-O-diphenyl-O ] diphenyl phosphite, 4, 8-tert-butyl-4-diphenyl-O-di-tert-butyl-4-diphenyl][1,3,2]Dioxaphosphepin (C), 6-fluoro-2, 4,8, 10-tetra-tert-butyl-12-methyl-dibenzo [ d, g][1,3,2]Dioxaphosphocyclooctane (A), bis (2, 4-di-tert-butyl-6-methylphenyl) methyl phosphite, bis (2, 4-di-tert-butyl-6-methylphenyl) ethyl phosphite (G), 2,2', 2 "-nitrilo [ triethyltris (3, 3', 5' -tetra-tert-butyl-1, 1' -biphenyl-2, 2' -diyl) phosphite](B) Bis (2, 4-di-tert-butylphenyl) octylphosphite, poly (4,4' - {2,2' dimethyl-5, 5' -di-tert-butylphenyl thio- } octylphosphite), poly (4,4' { -isopropylidenediphenol } -octylphosphite), poly (4,4' - { isopropylidenedi [2, 6-dibromophenol ] o]Octyl phosphite), poly (4,4' - {2,2' -dimethyl-5, 5' -di-tert-butylphenyl-thio } -pentaerythrityl tetrakisAlcohol diphosphite), phosphorous acid, mixed 2, 4-bis (1, 1-dimethylpropyl) phenyl and 4- (1, 1-dimethylpropyl) phenyl triester (CAS No.939402-02-5), phosphorous acid, triphenyl ester, having α -hydro-omega-hydroxypoly [ oxy (methyl-1, 2-ethanediyl)]Polymer of (2), C10-16Alkyl esters (CAS No.1227937-46-3),
Figure BDA0002396795310000301
Figure BDA0002396795310000311
Figure BDA0002396795310000321
in some embodiments, a combination of one or more organophosphorus stabilizers may be used.
In a particular embodiment, the organophosphorus stabilizer is selected from the group consisting of tris (nonylphenyl) phosphite, bis (2, 4-di-tert-butylphenyl) pentaerythritol diphosphite, bis (2, 4-di-tert-butyl-6-methylphenyl) ethyl phosphite, 2,2', 2 "-nitrilo [ triethyltris (3, 3', 5' -tetra-tert-butyl-1, 1' -biphenyl-2, 2' -diyl) phosphite ], bis (2, 4-di- α -cumylphenyl) pentaerythritol diphosphite, tris (2, 4-di-tert-butylphenyl) phosphite, and combinations thereof.
The benzofuranone stabilizer may be used in an amount ranging from any of about 20ppm, about 30ppm, about 40ppm, about 50ppm, about 60ppm, about 70ppm, about 80ppm, about 90ppm, about 100ppm, about 110ppm, about 120ppm, about 130ppm, about 140ppm, about 150ppm, about 160ppm, about 170ppm, about 180ppm, about 190ppm, about 200ppm, about 250ppm, about 300ppm, about 350ppm, about 400ppm, about 450ppm or about 500ppm by weight to any of about 550ppm, about 600ppm, about 650ppm, about 700ppm, about 750ppm, about 800ppm, about 850ppm, about 900ppm, about 950ppm, about 1250ppm, about 1050ppm, about 1100ppm, about 1150ppm, about 1200ppm, about 1250ppm, about 1300ppm, about 1350ppm or about 1400ppm by weight based on the weight of the polyolefin.
In other embodiments, the benzofuranone stabilizer can be used in an amount ranging from about 0.05 wt% (weight percent), about 0.07 wt%, about 0.09 wt%, about 0.10 wt%, about 0.15 wt%, about 0.20 wt%, about 0.25 wt%, about 0.30 wt%, about 0.35 wt%, about 0.40 wt%, about 0.50 wt%, about 0.60 wt%, about 0.65 wt%, about 0.70 wt%, about 0.75 wt%, about 0.80 wt%, about 0.90 wt%, about 1.0 wt%, about 1.3 wt%, about 1.5 wt%, about 1.7 wt%, about 2.0 wt%, about 2.5 wt%, about 3.0 wt%, about 3.5 wt%, about 4.0 wt%, about 4.5 wt%, about 5.0 wt%, or about 5 wt%, about 0.5 wt%, about 6.5 wt%, about 0.5 wt%, about 5.5 wt%, about 0.5 wt%, about 6.5 wt%, about 0.5 wt%, about 5 wt%, about 0.5 wt%, about 6.5 wt%, about 0.5 wt%, about 0 wt%, about 0.5 wt%, about 8.5 wt%, about 6 wt%, about 0.5 wt%, about 0 wt%, about 0.5 wt%, about 8.5 wt, Within a range of any of about 9.5 wt% or about 10.0 wt%, based on the weight of the polyolefin.
In other embodiments, the benzofuranone stabilizer can be used in an amount ranging from any of about 1 weight percent, about 5 weight percent, about 10 weight percent, about 15 weight percent, about 20 weight percent, about 25 weight percent, or about 30 weight percent to any of about 35 weight percent, about 40 weight percent, about 45 weight percent, or about 50 weight percent, based on the weight of the polyolefin.
The organophosphorus stabilizer may be used in an amount ranging from any of about 20ppm, about 30ppm, about 40ppm, about 50ppm, about 60ppm, about 70ppm, about 80ppm, about 90ppm, about 100ppm, about 110ppm, about 120ppm, about 130ppm, about 140ppm, about 150ppm, about 160ppm, about 170ppm, about 180ppm, about 190ppm, about 200ppm, about 250ppm, about 300ppm, about 350ppm, about 400ppm, about 450ppm, or about 500ppm to any of about 550ppm, about 600ppm, about 650ppm, about 700ppm, about 750ppm, about 800ppm, about 850ppm, about 900ppm, about 950ppm, about 1000ppm, about 1250ppm, about 1100ppm, about 1150ppm, about 1200ppm, about 1300ppm, about 1350ppm, or about 1400ppm by weight, based on the weight of the polyolefin.
In other embodiments, the organic phosphorus stabilizer may be used in an amount ranging from about 0.05 wt% (weight percent), about 0.07 wt%, about 0.09 wt%, about 0.10 wt%, about 0.15 wt%, about 0.20 wt%, about 0.35 wt%, about 0.50 wt%, about 0.75 wt%, about 0.1 wt%, about 0.2 wt%, about 0.3 wt%, about 0.4 wt%, about 0.5 wt%, about 0.6 wt%, about 0.7 wt%, about 0.8 wt%, about 0.9 wt%, about 1.0 wt%, about 1.3 wt%, about 1.5 wt%, about 1.7 wt%, about 2.0 wt%, about 2.5 wt%, about 3.0 wt%, about 3.5 wt%, about 4.0 wt%, about 4.5 wt%, about 5.0 wt%, about 5.5 wt%, about 0.5 wt%, about 5.5 wt%, about 0 wt%, about 0.5 wt%, about 8 wt%, about 0 wt%, about 0.5 wt%, about 0 wt%, about 0.5 wt%, about 5 wt%, about 0.5 wt%, about 0 wt%, about 5 wt%, about 0.5 wt%, about 8 wt%, about 0.5 wt%, about 0 wt%, about 0.5 wt%, about 8 wt%, about, Within a range of any of about 9.0 wt%, about 9.5 wt%, or about 10.0 wt%, based on the weight of the polyolefin.
In some embodiments, the weight/weight ratio between the one or more benzofuranones and the one or more organophosphorus stabilizers can be from any one of about 1/99, about 1/90, about 1/80, about 1/70, about 1/60, about 1/50, about 1/40, about 1/30, about 1/20, about 1/10, about 1/9, about 1/8, about 1/7, about 1/6, about 1/5, about 1/4, about 1/3, about 1/2, or about 1/1 to about 2/1, about 3/1, about 4/1, about 5/1, about 6/1, about 7/1, about 8/1, about 9/1, about 10/1, about 20/1, about 30/1, about 6384, About 40/1, about 50/1, about 60/1, about 70/1, about 80/1, about 90/1, or about 99/1.
In some embodiments, the organophosphorus stabilizer may be used in an amount by weight equal to or greater than the amount by weight of the one or more benzofuranones. For example, in some embodiments, the weight/weight ratio between the one or more benzofuranones and the one or more organophosphorus stabilizers can range from any one of about 0.05, about 0.10, about 0.15, about 0.20, about 0.25, about 0.30, about 0.35, about 0.40, about 0.45, or about 0.50 to any one of about 0.55, about 0.60, about 0.65, about 0.70, about 0.75, about 0.80, about 0.85, about 0.90, about 0.95, or about 1.0.
Also disclosed herein are additive compositions comprising one or more of the benzofuranone compounds and one or more organophosphorus stabilizers. The weight/weight ratio between the benzofuranone and the organophosphorus stabilizer can be set as described above.
In some embodiments, the composition may further comprise one or more additional additives selected from the group consisting of: antioxidants, ultraviolet light absorbers, hindered amine light stabilizers, acid scavengers, metal deactivators, hydroxylamines, nitrones, amine N-oxides, thiosynergists, peroxide scavengers, nucleating agents, fillers, flame retardants and antistatic agents.
In some embodiments, the additional additives may include plasticizers, lubricants, emulsifiers, pigments, dyes, optical brighteners, rheological additives, catalysts, flow control agents, slip agents, crosslinking promoters, halogen scavengers, smoke suppressants, antistatic agents, or clarifying agents, such as substituted and unsubstituted dibenzylidene sorbitol.
The additional additives, used alone or in combination, may range from any of about 20ppm, about 30ppm, about 40ppm, about 50ppm, about 60ppm, about 70ppm, about 80ppm, about 90ppm, about 100ppm, about 110ppm, about 120ppm, about 130ppm, about 140ppm, about 150ppm, about 160ppm, about 170ppm, about 180ppm, about 190ppm, about 200ppm, about 250ppm, about 300ppm, about 350ppm, about 400ppm, about 450ppm, or about 500ppm to any of about 550ppm, about 600ppm, about 650ppm, about 700ppm, about 750ppm, about 800ppm, about 850ppm, about 900ppm, about 950ppm, about 1000ppm, about 1250ppm, about 1100ppm, about 1150ppm, about 1200ppm, about 1300ppm, about 1350ppm, or about 1400ppm by weight based on the weight of the polyolefin.
In other embodiments, the additional additives, used alone or in combination, may be present in an amount ranging from about 0.05 wt% (weight percent), about 0.07 wt%, about 0.09 wt%, about 0.10 wt%, about 0.15 wt%, about 0.20 wt%, about 0.35 wt%, about 0.50 wt%, about 0.75 wt%, about 0.1 wt%, about 0.2 wt%, about 0.3 wt%, about 0.4 wt%, about 0.5 wt%, about 0.6 wt%, about 0.7 wt%, about 0.8 wt%, about 0.9 wt%, about 1.0 wt%, about 1.3 wt%, about 1.5 wt%, about 1.7 wt%, about 2.0 wt%, about 2.5 wt%, about 3.0 wt%, about 3.5 wt%, about 4.0 wt%, about 4.5 wt%, about 5.0 wt%, about 5.5 wt%, about 0.5 wt%, about 6.5 wt%, about 0.5 wt%, about 0 wt%, about 0.5 wt%, about 6 wt%, about 0.7 wt%, about 0.5 wt%, about 6 wt%, about 0.5 wt%, about 0 wt%, about 0.5 wt%, about 6 wt%, about 0.5 wt%, about 0 wt%, about 0.5 wt%, about 6, Within a range of any of about 8.5 wt%, about 9.0 wt%, about 9.5 wt%, or about 10.0 wt%, based on the weight of the polyolefin.
In some embodiments, the hindered amine light stabilizer is a compound containing one or more moieties of the formula:
Figure BDA0002396795310000361
wherein R is1、R2、R3And R4Independently methyl or ethyl, and wherein R is H, methyl, hydroxy, propoxy, octyloxy, cyclohexyloxy, acyloxy or N- (2-hydroxy-2-methylpropyloxy).
Suitable hindered amine light stabilizers are, for example:
(1) 1-cyclohexyloxy-2, 2,6, 6-tetramethyl-4-octadecylaminopiperidine,
(2) bis (2,2,6, 6-tetramethylpiperidin-4-yl) sebacate,
(3) bis (1-acetoxy-2, 2,6, 6-tetramethylpiperidin-4-yl) sebacate,
(4) bis (1,2,2,6, 6-pentamethylpiperidin-4-yl) sebacate,
(5) bis (1-cyclohexyloxy-2, 2,6, 6-tetramethylpiperidin-4-yl) sebacate,
(6) bis (1-octyloxy-2, 2,6, 6-tetramethylpiperidin-4-yl) sebacate;
(7) bis (1-acyl-2, 2,6, 6-tetramethylpiperidin-4-yl) sebacate,
(8) bis (1,2,2,6, 6-pentamethyl-4-piperidinyl) -n-butyl-3, 5-di-tert-butyl-4-hydroxybenzylmalonate
(9)2, 4-bis [ (1-cyclohexyloxy-2, 2,6, 6-tetramethylpiperidin-4-yl) butylamino ] -6- (2-hydroxyethylamino-s-triazine,
(10) bis (1-cyclohexyloxy-2, 2,6, 6-tetramethylpiperidin-4-yl) adipate,
(11)2, 4-bis [ (1-cyclohexyloxy-2, 2,6, 6-piperidin-4-yl) butylamino ] -6-chloro-s-triazine,
(12)1- (2-hydroxy-2-methylpropoxy) -4-hydroxy-2, 2,6, 6-tetramethylpiperidine,
(13)1- (2-hydroxy-2-methylpropoxy) -4-oxo-2, 2,6, 6-tetramethylpiperidine,
(14)1- (2-hydroxy-2-methylpropoxy) -4-octadecanoyloxy-2, 2,6, 6-tetramethylpiperidine,
(15) bis (1- (2-hydroxy-2-methylpropoxy) -2,2,6, 6-tetramethylpiperidin-4-yl) sebacate,
(16) bis (1- (2-hydroxy-2-methylpropoxy) -2,2,6, 6-tetramethylpiperidin-4-yl) adipate,
(17)2, 4-bis { N- [1- (2-hydroxy-2-methylpropoxy) -2,2,6, 6-tetramethylpiperidin-4-yl ] -N-butylamino } -6- (2-hydroxyethylamino) -s-triazine,
(18) 4-benzoyl-2, 2,6, 6-tetramethylpiperidine,
(19) bis- (1,2,2,6, 6-pentamethylpiperidin-4-yl) -p-methoxybenzylidene malonate,
(20)2,2,6, 6-tetramethylpiperidin-4-yl octadecanoate,
(21) bis (1-octyloxy-2, 2,6, 6-tetramethylpiperidyl) succinate,
(22)1,2,2,6, 6-pentamethyl-4-aminopiperidine,
(23) 2-undecyl-7, 7,9, 9-tetramethyl-1-oxa-3, 8-diaza-4-oxo-spiro [4,5] decane,
(24) tris (2,2,6, 6-tetramethyl-4-piperidyl) nitrilotriacetate,
(25) tris (2-hydroxy-3- (amino- (2,2,6, 6-tetramethylpiperidin-4-yl) propyl) nitrilotriacetate,
(26) tetrakis (2,2,6, 6-tetramethyl-4-piperidyl) -1,2,3, 4-butane-tetracarboxylate,
(27) tetrakis (1,2,2,6, 6-pentamethyl-4-piperidinyl) -1,2,3, 4-butane-tetracarboxylate,
(28)1,1' - (1, 2-ethanediyl) -bis (3,3,5, 5-tetramethylpiperazinone),
(29) 3-n-octyl-7, 7,9, 9-tetramethyl-1, 3, 8-triazaspiro [4.5] decane-2, 4-dione,
(30) 8-acetyl-3-dodecyl-7, 7,9, 9-tetramethyl-1, 3, 8-triazaspiro [4.5] decane-2, 4-dione,
(31) 3-dodecyl-1- (2,2,6, 6-tetramethyl-4-piperidyl) pyrrolidine-2, 5-dione,
(32) 3-dodecyl-1- (1,2,2,6, 6-pentamethyl-4-piperidyl) pyrrolidine-2, 5-dione,
(33) n, N '-di-formyl-N, N' -di (2,2,6, 6-tetramethyl-4-piperidyl) hexamethylenediamine,
(33a) bis (1-undecanoyl-2, 2,6, 6-tetramethylpiperidin-4-yl) carbonate,
(34) the reaction product of 2, 4-bis [ (1-cyclohexyloxy-2, 2,6, 6-piperidin-4-yl) butylamino ] -6-chloro-s-triazine with N, N' -bis (3-aminopropyl) ethylenediamine),
(35) a condensate of 1- (2-hydroxyethyl) -2,2,6, 6-tetramethyl-4-hydroxypiperidine and succinic acid,
(36) the condensate of N, N' -bis (2,2,6, 6-tetramethyl-4-piperidyl) -hexamethylenediamine and 4-tert-octylamino-2, 6-dichloro-1, 3, 5-triazine,
(37) the condensate of N, N' -bis (2,2,6, 6-tetramethyl-4-piperidyl) -hexamethylenediamine and 4-cyclohexylamino-2, 6-dichloro-1, 3, 5-triazine,
(38) a condensate of N, N' -bis- (2,2,6, 6-tetramethyl-4-piperidyl) hexamethylenediamine and 4-morpholino-2, 6-dichloro-1, 3, 5-triazine,
(39) a condensate of N, N' -bis- (1,2,2,6, 6-pentamethyl-4-piperidyl) hexamethylenediamine and 4-morpholino-2, 6-dichloro-1, 3, 5-triazine,
(40) a condensate of 2-chloro-4, 6-bis (4-n-butylamino-2, 2,6, 6-tetramethylpiperidyl) -1,3, 5-triazine and 1, 2-bis (3-aminopropylamino) ethane,
(41) a condensate of 2-chloro-4, 6-bis- (4-n-butylamino-1, 2,2,6, 6-pentamethylpiperidyl) -1,3, 5-triazine with 1, 2-bis- (3-aminopropylamino) ethane,
(42) a reaction product of 7,7,9, 9-tetramethyl-2-cycloundecyl-1-oxa-3, 8-diaza-4-oxospiro [4,5] decane and epichlorohydrin,
(43) poly [ methyl, (3-oxy- (2,2,6, 6-tetramethylpiperidin-4-yl) propyl) ] siloxane, CAS #182635-99-0,
(44) maleic anhydride-C18-C22- α -the reaction product of an olefin copolymer with 2,2,6, 6-tetramethyl-4-aminopiperidine,
(45) oligomeric condensates of 4,4' -hexamethylenebis (amino-2, 2,6, 6-tetramethylpiperidine) with 2, 4-dichloro-6- [ (2,2,6, 6-tetramethylpiperidin-4-yl) butylamino ] -s-triazine, terminated with 2-chloro-4, 6-bis (dibutylamino) -s-triazine,
(46) oligomeric condensates of 4,4' -hexamethylenebis (amino-1, 2,2,6, 6-pentamethylpiperidine) with 2, 4-dichloro-6- [ (1,2,2,6, 6-pentamethylpiperidin-4-yl) butylamino ] -s-triazine, which are end-capped with 2-chloro-4, 6-bis (dibutylamino) -s-triazine,
(47) oligomeric condensates of 4,4' -hexamethylenebis (amino-1-propoxy-2, 2,6, 6-tetramethylpiperidine) with 2, 4-dichloro-6- [ (1-propoxy-2, 2,6, 6-tetramethylpiperidin-4-yl) butylamino ] -s-triazine, terminated with 2-chloro-4, 6-bis (dibutylamino) -s-triazine,
(48) oligomeric condensates of 4,4' -hexamethylenebis (amino-1-acyloxy-2, 2,6, 6-tetramethylpiperidine) with 2, 4-dichloro-6- [ (1-acetoxy-2, 2,6, 6-tetramethylpiperidin-4-yl) butylamino ] -s-triazine, terminated with 2-chloro-4, 6-bis (dibutylamino) -s-triazine,
(49) a product obtained by reacting (a) a product obtained by reacting 1, 2-bis (3-aminopropylamino) ethane with cyanuric chloride and (b) a product obtained by reacting (2,2,6, 6-tetramethylpiperidin-4-yl) butylamine,
(50) (4-piperidinol, 2,2,6, 6-tetramethyl-1- (undecyloxy)) -,4,4' -carbonate, and
(51)1,3, 5-triazine-2, 4, 6-triamine, N2, N2' -1, 6-hexanediylbis [ N4, N6-dibutyl-N2, N4, N6-tris (2,2,6, 6-tetramethyl-4-piperidinyl) -, N-propoxy.
Also included are the sterically hindered N-H, N-methyl, N-methoxy, N-hydroxy, N-propoxy, N-octyloxy, N-cyclohexyloxy, N-acyloxy and N- (2-hydroxy-2-methylpropyloxy) analogs of any of the foregoing compounds. For example, in the case of replacing the N-H hindered amine with an N-methyl hindered amine, the N-methyl analog would be used in place of N-H.
For illustrative purposes, some structures of the above compounds are shown below.
(6)
Figure BDA0002396795310000391
(8)
Figure BDA0002396795310000392
(9)
Figure BDA0002396795310000393
(12)
Figure BDA0002396795310000401
(19)
Figure BDA0002396795310000402
(23)
Figure BDA0002396795310000403
(25)
Figure BDA0002396795310000404
(26)
Figure BDA0002396795310000405
(28)
Figure BDA0002396795310000411
(29)
Figure BDA0002396795310000412
(31)
Figure BDA0002396795310000413
(33)
Figure BDA0002396795310000414
(34)
Figure BDA0002396795310000415
(35)
Figure BDA0002396795310000416
(36)
Figure BDA0002396795310000421
(38)
Figure BDA0002396795310000422
(41)
Figure BDA0002396795310000423
(42)
Figure BDA0002396795310000424
(43)
Figure BDA0002396795310000431
(44)
Figure BDA0002396795310000432
(45)
Figure BDA0002396795310000433
(49)
Figure BDA0002396795310000441
Wherein R '═ R' or H,
n is 2 or 3, and n is 2 or 3,
and wherein
Figure BDA0002396795310000442
Figure BDA0002396795310000443
Figure BDA0002396795310000451
In particular embodiments, the composition may further comprise a hindered phenolic antioxidant, such as β - (3, 5-di-tert-butyl-4-hydroxyphenyl) propionate, for example an ester of a mono-or polyhydric alcohol, for example with methanol, ethanol, n-octanol, isooctanol, linear and branched C7-C9Mixture of alkanols, stearyl alcohol, straight-chain and branched C13-C15Mixtures of alkanols, 1, 6-hexanediol, 1, 9-nonanediol, ethylene glycol, 1, 2-propanediol, 1, 3-propanediol, neopentyl glycol, 1, 4-cyclohexanedimethanol, glycerol, thiodiethylene glycol, diethylene glycol, triethylene glycol, pentaerythritol, tris (hydroxyethyl) isocyanurate, N, N' -bis- (hydroxy-ethyl) oxamide, 3-thiaundecanol, 3-thiapentadecanol, trimethylhexanediol, trimethylolpropane, 4-hydroxymethyl-1-phospha-2, 6, 7-trioxabicyclo [2.2.2 ] trioxabicyclo [2.2]Octane.
In other embodiments, the hindered phenolic antioxidant comprises tris (3, 5-di-tert-butyl-4-hydroxybenzyl) isocyanurate, 1,3, 5-tris- (3, 5-di-tert-butyl-4-hydroxybenzyl) -2,4, 6-trimethylbenzene, the calcium salt of the monoethyl ester of 3, 5-di-tert-butyl-4-hydroxybenzylphosphonic acid, 1, 2-bis (3, 5-di-tert-butyl-4-hydroxyhydrocinnamoyl) hydrazine, pentaerythrityl tetrakis [3- (3, 5-di-tert-butyl-4-hydroxyphenyl) propionate ], octadecyl 3- (3, 5-di-tert-butyl-4-hydroxyphenyl) propionate, N '-hexamethylenebis (3, 5-di-tert-butyl-4-hydroxyhydrocinnamide), 1,3, 5-tris- (4-tert-butyl-3-hydroxy-2, 6-dimethylbenzyl) -1,3, 5-triazine-2, 4,6- (1H,3H,5H) -trione, 2,2' -methylenebis (4-methyl-6-t-butylphenol) α or tocopheryl mono-acrylate.
In some embodiments, the composition is substantially free or free of hindered phenol antioxidants. "substantially free" means unintentionally added in which there are only incidental amounts or trace amounts, such as less than or equal to 500ppm (parts per million) by weight, less than or equal to 400ppm, less than or equal to 300ppm, less than or equal to 200ppm, less than or equal to 150ppm, less than or equal to 100ppm, less than or equal to 75ppm, less than or equal to 50ppm, less than or equal to 25ppm, less than or equal to 20ppm, less than or equal to 15ppm, less than or equal to 10ppm, less than or equal to 5ppm, less than or equal to 4ppm, less than or equal to 3ppm, less than or equal to 2ppm or less than 1ppm, based on the weight of the polyolefin.
Thiosynergists include, for example, dilauryl thiodipropionate or distearyl thiodipropionate.
Acid scavengers include hydrotalcite and amorphous basic aluminum magnesium carbonate, see, for example, U.S. patent nos.4,427,816, 5,106,898 and 5,234,981. Hydrotalcite is also known as hycite, DHT4A, DHT4V, DHT4Z, DHT4a2 or DHT 4C. Hydrotalcites are natural or synthetic, and may contain a coating. Natural hydrotalcite is believed to have the structure Mg6Al2(OH)16CO3.4H2And O. A typical empirical formula for the synthetic hydrotalcite is Al2Mg4.35OH11.36CO3(1.67).xH2And O. Examples of synthetic products include Mg0.7Al0.3(OH)2(CO3)0.15.0.54H2O、Mg4.5Al2(OH)13CO3.3.5H2O and Mg4.2Al(OH)12.4CO3
In some embodiments, the acid scavenger comprises a metal salt of a fatty acid, such as an alkali metal salt or an alkaline earth metal salt of a fatty acid. In some embodiments, the acid scavenger comprises a calcium, magnesium, zinc, sodium, potassium, or aluminum salt of a fatty acid. In some embodiments, the acid scavenger comprises a stearate, behenate, ricinoleate, or palmitate salt of calcium, magnesium, zinc, sodium, potassium, or aluminum. In particular embodiments, the acid scavenger comprises calcium stearate, zinc stearate, magnesium behenate, magnesium stearate, sodium ricinoleate, and potassium palmitate. In other embodiments, the acid scavenger comprises zinc oxide.
In some embodiments, a combination of one or more acid scavengers may be used.
The Ultraviolet (UV) light absorber may be selected from the group consisting of hydroxyphenylbenzotriazoles, triaryl-s-triazines, hydroxybenzoates, 2-hydroxybenzophenones and cyanoacrylate ultraviolet light absorbers (UVAs).
Hydroxyphenyl benzotriazole UVA may include those disclosed in U.S. Pat. Nos.3,004,896;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;. 5,607,987,5,977,219, and 6,166,218; -such as 2- (2-hydroxy-5-methylphenyl) -2H-benzotriazole, 2- (3, 5-di-tert-butyl-2-hydroxyphenyl) -2H-benzotriazole, 2- (2-hydroxy-5-tert-butylphenyl) -2H-benzotriazole, 2- (2-hydroxy-5-tert-butylphenyl) -2H-benzotriazole, 2- (3, 5-di-tert-butyl-2-octyloxy) -2H-benzotriazole, 5-chloro-2- (3, 5-di-tert-butyl-2-hydroxyphenyl) -2H-benzotriazole, 5-2- (2-t-octylphenyl) -2H-benzotriazolyl) -2H-benzotriazole, 5-2-octyloxy-2- (2, 2-tert-butyl-2-hydroxyphenyl) -2H-benzotriazolyl) -2H-benzotriazole, 5- (2-2H-phenyloctyl-2H-triazolyl) -2H-2, 5- (2H-2-octyloxy-2, 5-2H-tert-2-tert-octyloxy) -2H-2, 5-tert-2-tert-phenyl) -2H-benzotriazolyl) -2H-2-octyloxy-2, 2H-2H-2-tert-octyloxy-2, 2-2H-2, 2-2H-2-tert-2, 5-2-octyloxy-2H-2-octyloxy-2, 5-2, 5-2H-2, 5-2H-2H-tert-2-octyloxy-2H-2, 5-tert-2H-2-octyloxy-2H-2H-2, 5-2H-2, 5-2H-2H-2, 5-2H-2-phenyl) -2, 5-2H-2H-2-phenyl-2H-2-.
Triaryl-s-triazine UVA may include those disclosed in U.S. Pat. No. 3,843,371; 4,619,956; 4,740,542; 5,096,489; 5,106,891; 5,298,067; 5,300,414; 5,354,794; 5,461,151; 5,476,937; 5,489,503; 5,543,518; 5,556,973; 5,597,854; 5,681,955; 5,726,309; 5,736,597; 5,942,626; 5,942,626; 5,942,626; and U.S. applications disclose those disclosed in U.S. Pat. No. 5/5,942,626 and U.S. application Nos.2, 4, 6-tris (2-hydroxy-3-methyl-4-hexyloxyphenyl) -1,3, 5-triazine, dodecanedioic acid, 1, 12-bis [2- [4- (4, 6-diphenyl-1, 3, 5-triazine-2-yl) -3-hydroxyphenoxy ] ethyl ] ester, 4, 6-bis- (2, 4-dimethylphenyl) -2- (2-hydroxy-4-octyloxyphenyl) -s-triazine-s-2- (2-hydroxy-propoxy) -2, 6-propyloxy) -2, 6-bis- (2-octyloxy) -2-phenyl) -2-hydroxy-propyloxy) -1,3, 6-bis- (2-phenyl) -4-propyloxy) -2-bis- (2-hydroxy-propyloxy) -2, 6-bis- (2-phenyl) -2-4-hydroxy-propyloxy) -1, 6-bis- (2-phenyl) -6-bis- (2-bis- (4-octyloxy) -2-hydroxy-propyloxy) -1, 6-phenyl) -6-bis- (2-phenyl) -2-bis- (2-hydroxy-phenyl) -4-propyloxy) -6-bis- (2-hydroxy-propyloxy) -6-phenyl) -6-bis- (2-hydroxy-phenyl) -6-bis- (2-propyloxy-bis- (2-phenyl) -6-4-propyloxy-4-phenyl) -6-bis- (2-phenyl) -6-phenyl) -4-bis- (2-phenyl) -6-bis- (2-hydroxy-phenyl) -1, 6-hydroxy-propyloxy-phenyl) -6-bis- (2-phenyl) -1, 6-phenyl) -6-bis- (2-propyloxy-4-phenyl) -6-bis- (2-hydroxy-phenyl) -4-hydroxy-propyloxy-phenyl) -6-bis- (2-phenyl) -1, 6-phenyl) -4-bis- (2-propyloxy-phenyl) -4-propyloxy-phenyl) -1, 6-hydroxy-4-propyloxy-phenyl) -6-hydroxy-phenyl) -6-hydroxy-phenyl) -1, 6-phenyl) -6-bis- (2-phenyl) -4-phenyl) -1, 6-phenyl) -6-bis- (2-4-phenyl) -6-phenyl) -1, 6-phenyl) -4-phenyl) -6-bis- (2-phenyl) -6-phenyl) -4-bis- (2-hydroxy-phenyl) -1, 6-phenyl) -4-bis- (2-phenyl) -4-phenyl) -1, 6-bis- (2-propyloxy-phenyl) -6-phenyl) -4-propyloxy-phenyl) -1, 6-phenyl) -6-bis- (2-propyloxy-phenyl) -6-bis- (2-phenyl) -6-propyloxy-phenyl) -6-bis- (2-phenyl) -1, 6-bis- (2-phenyl) -6-bis- (2-phenyl) -6-bis- (2-phenyl) -6-bis- (.
Hydroxybenzoate UV absorbers may include, for example, esters of substituted and unsubstituted benzoic acids, such as 4-tert-butylphenyl salicylate, phenyl salicylate, octylphenyl salicylate, dibenzoyl resorcinol, bis (4-tert-butylbenzoyl) resorcinol, benzoyl resorcinol, 2, 4-di-tert-butylphenyl 3, 5-di-tert-butyl-4-hydroxybenzoate, hexadecyl 3, 5-di-tert-butyl-4-hydroxybenzoate, octadecyl 3, 5-di-tert-butyl-4-hydroxybenzoate, 2-methyl-4, 6-di-tert-butylphenyl 3, 5-di-tert-butyl-4-hydroxybenzoate.
2-hydroxybenzophenone UV absorbers include, for example, the 4-hydroxy, 4-methoxy, 4-octyloxy, 4-decyloxy, 4-dodecyloxy, 4-benzyloxy, 4,2',4' -trihydroxy and 2 '-hydroxy-4, 4' -dimethoxy derivatives.
Cyanoacrylate UV absorbers include, for example, pentaerythritol tetrakis (2-cyano-3, 3-diphenylacrylate), ethyl or isooctyl α -cyano- β -diphenylacrylate, and α -cyano- β -methyl-p-methoxy-cinnamic acid methyl or butyl ester.
In some embodiments, the UVA may include 5-chloro-2- (3-tert-butyl-2-hydroxy-5-methylphenyl) -2H-benzotriazole, 2- (3, 5-bis- α -cumyl-2-hydroxyphenyl) -2H-benzotriazole, 4, 6-diphenyl-2- (4-hexyloxy-2-hydroxyphenyl) -s-triazine, 4, 6-bis- (2, 4-dimethylphenyl) -2- (2-hydroxy-4-octyloxyphenyl) -s-triazine, hexadecyl 3, 5-di-tert-butyl-4-hydroxybenzoate or 4-octyloxy-2-hydroxybenzophenone.
Many UVAs are commercially available, such as TINUVIN 326, TINUVIN 234, TINUVIN 1577, TINUVIN1600, CYASORB UV 1164, CYASORB THT, CYASORB UV 2908, CHIMASSORB 81, UVINUL 3030, ADK LA-F70, ADK LA-1000, TINUVIN 400, and the like.
Hydroxylamine stabilizers may include, for example: n, N-dibenzylhydroxylamine, N, N-diethylhydroxylamine, N, N-dioctylhydroxylamine, N, N-dilaurylhydroxylamine, N, N-didodecylhydroxylamine, N, N-ditetradecylhydroxylamine, N, N-dihexadecylhydroxylamine, N, N-dioctadecylhydroxylamine, N-hexadecyl-N-tetradecylhydroxylamine, N-hexadecyl-N-heptadecylhydroxylamine, N-hexadecyl-N-decadecylhydroxylamineOctaalkylhydroxylamine, N-heptadecyl-N-octadecylhydroxylamine, N-methyl-N-octadecylhydroxylamine, or in particular embodiments N, N-di (C)16-C18Alkyl) hydroxylamine.
In particular embodiments, the polyolefin comprises a Polyethylene (PE) homopolymer, a polyethylene random or block copolymer, a polypropylene (PP) homopolymer, a polypropylene random or block copolymer, an ethylene/propylene copolymer, a mixture of polypropylene and polyethylene, or a mixture of different types of polyethylene. In a particular embodiment, the polyolefin is polypropylene. In some embodiments, the polyethylene is Linear Low Density (LLDPE), Low Density (LDPE), Medium Density (MDPE), or High Density (HDPE). Such mixtures are, for example, PP/HDPE, PP/LDPE and LDPE/HDPE. Ternary mixtures, such as PP/HDPE/LLDPE, are also included. The polyolefins may be formulated with or without crosslinking.
The polyolefin composition contains, for example, greater than or equal to about 10 weight percent (wt.%) of a polyolefin, such as greater than or equal to about 15 wt.%, > or equal to about 20 wt.%, > or equal to about 25 wt.%, > or equal to about 30 wt.%, > or equal to about 35 wt.%, > or equal to about 40 wt.%, > or equal to about 45 wt.%, > or equal to about 50 wt.%, > or equal to about 55 wt.%, > or equal to about 60 wt.%, > or equal to about 65 wt.%, > or equal to about 70 wt.%, > or equal to about 75 wt.%, > or equal to about 80 wt.% or greater than or equal to about 85 wt.% of the polyolefin, based on the weight of the composition.
The polypropylene may be a polypropylene homopolymer, polypropylene random copolymer, alternating or segmented copolymer or block copolymer containing one or more comonomers selected from the group consisting of: ethylene, C4-C30- α -olefin, vinylcyclohexane, vinylcyclohexene, C4-C20Alkadienes of C5-C12Cycloalkadienes and norbornene derivatives; the total amount of propylene and one or more comonomers is 100%.
Polypropylene copolymers also include long chain branched polypropylene copolymers.
Suitable C4-C30α examples of olefins are 1-butene, 1-pentene, 1-hexene, 1-heptene, 1-octene, 1-nonene, 1-decene, 1-undecene, 1-dodecene1-tetradecene, 1-hexadecene, 1-octadecene, 1-eicosene, 4-methyl-1-pentene, 1-eicosene, 1-docosene, 1-tetracosene, 1-hexacosene, 1-octacosene, and 1-triacontene.
Suitable C4-C20Examples of the alkadienes include hexadiene and octadiene. Suitable C5-C12Examples of the cycloalkane diene include cyclopentadiene, cyclohexadiene and cyclooctadiene. Examples of suitable norbornene derivatives include 5-ethylidene-2-norbornene (ENB), Dicyclopentadiene (DCP) and methylene-endomethylene-hexahydronaphthalene (MEN).
The propylene/ethylene copolymer contains, for example, from about 50 to 99.9%, in some embodiments from about 80 to 99.9%, and in other embodiments, from about 90 to 99.9% by weight propylene.
Propylene copolymer wherein the comonomer is C9-C20α -alkenes, for example 1-nonene, 1-decene, 1-undecene, 1-dodecene, 1-tetradecene, 1-hexadecene, 1-octadecene or 1-eicosene, C9-C20Alkadienes of C9-C12Cycloalkadienes or norbornene derivatives, such as 5-ethylidene-2-norbornene (ENB) or methylene-endomethylene-hexahydronaphthalene (MEN), such propylene copolymers may contain greater than about 90 mole%, from about 90 mole% to about 99.9 mole%, or from about 90 mole% to about 99 mole% propylene.
Propylene copolymer wherein the comonomer is C4-C8α -olefins, e.g. 1-butene, 1-pentene, 1-hexene, 1-heptene, 1-octene or 4-methyl-1-pentene, vinylcyclohexane, vinylcyclohexene, C4-C8Alkadienes or C5-C8Naphthenic dienes such propylene copolymers may contain greater than 80 mole percent, from about 80 to about 99.9 mole percent, or from about 80 to about 99 mole percent propylene.
Other examples of polypropylene are propylene/isobutylene copolymers, propylene/butadiene copolymers, propylene/cycloolefin copolymers, terpolymers of propylene with ethylene and a diene, such as hexadiene, dicyclopentadiene or ethylidene-norbornene; propylene/1-olefin copolymers wherein the 1-olefin is produced in situ; and propylene/carbon monoxide copolymers.
Allyl or vinyl terminated oligomers of ethylene or propylene can be used as branches in polymerization reactions with propylene to produce branched polypropylene with high melt strength, see, for example, U.S. patent No.8,399,725 and U.S. application publication nos.2013/0274425,2013/0274425,2013/0030135 and 2013/0137829.
The linear chain structure of polypropylene allows the polymer to exhibit low melt strength and lack strain hardening. This can lead to processing problems where the polymer is required to have extensibility. In contrast, polypropylene exhibiting high melt strength is valuable in industrial converting operations, such as blow molding, thermoforming, or foaming of polypropylene sheets. The polypropylene-based compositions of the present invention exhibit acceptable melt strength, ductility and strain hardening to produce extruded profiles and siding.
Advantageously, the polyolefin comprises a polypropylene homopolymer or copolymer, optionally blended with a polyethylene homopolymer or copolymer, having suitably high melt strength. The blend may further contain a third polymer suitable for promoting compatibility, partial miscibility or miscibility of the different polyolefins. Such materials are known as interfacial tension reducers or compatibilizers.
Suitable compatibilizers are generally polymers containing two or more different segments that are miscible or compatible with the components to be blended. Compatibilized polymer blends need not be completely miscible, nor need all mixing thermodynamics (e.g., resulting in a single phase, or a single glass transition temperature) be satisfied. But such a blend of different polymer structures will show improved properties compared to the individual components.
One compatibilizer used to blend PP and PE is a segmented "olefin block copolymer" or "OBC" containing propylene, ethylene and optionally additional α -olefin sequences, such as those produced by Dow Global Technologies, and see U.S. application publication nos.2011/032621,2011/060103,2010/298515,2011/054121 and 2011/015354, which includes therein the Dow product under the trade name INFUSE and the VISTAMAXX product of ExxonMobil, these block copolymers are made with a bulk molecular weight distribution and a segment molecular weight distribution such that Mw/Mn >1.4, with two or more blocks of ethylene and α -olefins per chain and a low molecular weight (Mw <200,000g/mol), these alternating block copolymers are characterized by a crystallizable tough 'hard block' segment and an amorphous elastomeric 'soft block' content, the hard block content in these c is 12-84 wt%, and the total 1-octene content (i.e., the branched HDPE) is 3-14 wt%, where the blend can achieve increased tensile strength and elongation compared to long chain compatibilized OBC blends and obps.
Polypropylene homopolymers or copolymers or blends with polyethylene, optionally compatibilized, can be chemically crosslinked to introduce Long Chain Branching (LCB) outside the polypropylene backbone, resulting in higher melt strength and elongation and lower melt flow rates than conventional products.
Chemical crosslinking of a polypropylene homopolymer or copolymer with another polypropylene or with a polyethylene homopolymer or copolymer and/or with a compatibilizing material is advantageous. This crosslinking process can impart beneficial increases in melt strength, melt extensibility, mechanical strength, and tensile strength in the extrusion process to the polyolefin blend. Crosslinking on polypropylene can produce Long Chain Branching (LCB) in the polypropylene backbone and increased amounts of polymer chain entanglement to achieve higher polymer melt strength.
Crosslinking may be carried out with reagents such as organic peroxides, or by treatment with a radiation source, such as ultraviolet light, electron beam or gamma radiation. Irradiation may be accomplished in a reduced oxygen environment or an oxygen-free environment. For example, polypropylene having high melt strength and melt extensibility can be obtained by blending linear polypropylene with branched polypropylene (b-PP) in an extruder. b-PP is obtained by reacting a peroxide with an unmodified polypropylene and optionally a difunctional unsaturated monomer capable of grafting onto the unmodified polypropylene, resulting in long chain branching, see US 2015175789. In another example, U.S. Pat. Nos.5,508,318, 5,731,362, 5,591,785, 5,554,668, and 4,916,198 disclose mixing blends of irradiated and unirradiated olefin polymer materials suitable for extrusion.
The formation of long chain branches on polyolefins may be performed upstream during the production of the polymer, as compared to downstream extrusion or the case where the polymer is chemically modified to form crosslinks or long chain branches to improve melt strength. For example, polyethylene can be modified in the polymerization unit via exposure to low levels of oxygen, a so-called 'oxygen engineering', which results in the formation of long branches and improved melt strength, see U.S. application publication No. 2012/100357.
The polyolefin may contain additives that promote a higher degree of crystallization when the polymer is melt converted into a shaped article. Such additives are known as nucleating agents.
The crystallinity of polypropylene is an important parameter that can affect properties such as modulus, yield stress, strength, and the like. It is within the scope of the present invention to use nucleating agents that can favorably influence the degree of crystallinity formed, which improves the melt strength of the polymer during extrusion processing and improves the mechanical properties of the final article. Suitable nucleating agents are, for example, sodium benzoate, 2,2' -methylene-bis (4, 6-di-tert-butylphenyl) phosphate, zinc glycerolate, the calcium salt of cyclohexane-1, 2-dicarboxylate, the aromatic triamide compound, the disodium salt of cis-bridged-bicyclo [2.2.1] heptane-2, 3-dicarboxylic acid, aluminum hydroxy-bis [4- (tert-butyl) benzoate ], and sorbitol, for example 1,3:2, 4-bis (3, 4-dimethylbenzylidene) sorbitol, 1,3:2, 4-bis (4-methylbenzylidene) sorbitol or 1,3:2, 4-bis (3, 4-dimethylbenzylidene) sorbitol, see U.S. Pat. Nos.7,423,088, 7,790,793 and 8,183,312 and U.S. application publication No. 2012/0190797.
The nucleating agent may be present in an amount of, for example, from about 10 parts per million (ppm) to about 10,000ppm, from about 12ppm to about 1,000ppm, from about 12ppm to about 500ppm, or from about 12ppm to about 300ppm or about 400ppm by weight based on the weight of the polyolefin.
The polyolefin advantageously contains inorganic (mineral) fillers to balance melt strength and extensibility or stretchability, allowing extrusion to produce profiles and siding. The filler is described in more detail below.
The polyolefin comprises a polypropylene homopolymer or copolymer optionally blended with a polyethylene homopolymer or copolymer, wherein the blend may further contain a compatibilizer that can exhibit high melt strength. The polyolefin may have a melt strength of at least about 4 centinewtons (cN) at 210 ℃. For example, the polyolefin has a melt strength of about 4, about 5, about 6, about 7, about 8, about 9, about 10, about 11, about 12, about 13, about 14, about 15, about 16, about 17, about 18, about 19, about 20, about 21, about 22, about 23, about 24, or about 25 centinewtons at 210 ℃. For example, a melt strength of greater than or equal to about 5, greater than or equal to about 7, greater than or equal to about 9, greater than or equal to about 11, greater than or equal to about 13, greater than or equal to about 15, greater than or equal to about 17, greater than or equal to about 19, greater than or equal to about 21, or greater than or equal to about 23 centiNewtons at 210 ℃.
Polyolefins may be prepared by the following process:
a) free radical polymerization (usually carried out under high pressure and high temperature), or
b) Catalytic polymerisation using a catalyst which typically contains one or more metals of groups IVb, Vb, VIb or VIII of the periodic Table. These metals typically have one or more ligands, typically oxides, halides, alkoxides, esters, ethers, amines, alkyls, alkenyls, and/or aryls, which may be pi-or sigma-coordinated. These metal complexes may be in the free form or fixed on substrates, usually on activated magnesium chloride, titanium (III) chloride, alumina or silicon oxide. These catalysts may be soluble or insoluble in the polymerization medium. The catalyst may be used as such in the polymerization, or other activators may be used, typically metal alkyls, metal hydrides, metal alkyl halides, metal alkyl oxides or metal alkoxides, the metals being elements of groups Ia, IIa and/or IIIa of the periodic Table. The activators may be modified conveniently with further ester, ether, amine or silyl ether groups. These catalyst systems are generally known as Phillips, Standard OilIngiana, Ziegler (-Natta), TNZ (DuPont), metallocene or Single Site Catalysts (SSC).
Polypropylene is prepared by a process described in the literature including: kissin, Y.V, (2008), olefin polymerization using transition metal catalysts, Elsevier, pp.207-. ISBN 978-0-444-; hoff, Ray and Mathers, Robert T. (2010), handbook of transition metal polymerization catalysts, John Wiley & Sons, pp.158-ISBN 978-0-470-; moore, E.P, (1996) polypropylene handbook, polymerization, characterization, performance, processing, applications, hanser publishers: new York, ISBN 1569902089; benedikt, g.m. and Goodall, B.L. (ed) (1998) metallocene-catalyzed polymers, ChemTech Publishing: toronto, ISBN 978-1-884207-59-4; malpass, d.b., introduction to industrial polyethylene, properties, catalysts, processes, Wiley publ., (2010); and Malpass, d.b., introduction to industrial polyethylene, properties, catalysts, processes, Wiley publ., (2012).
In some embodiments, the polyolefin comprises a base polyolefin, a polyolefin recycle, or a mixture thereof. The polyolefin recycle may be collected from household, commercial or industrial waste or from usable materials. The recycled material may come from packaging materials such as films, bags, bottles and other containers or foam materials. It is also possible to stabilize polyolefins which have previously been damaged by use, storage or processing. These materials come, for example, from the collection or recycling duties of usable materials, for example from the automotive industry, the electronics/electrical industry, the construction, agriculture or textile industry.
The introduction of the benzofuranones and the organophosphorus stabilizers into the polyolefin is carried out by known methods, for example before or after moulding, or by applying the dissolved or dispersed additive mixture to the polyolefin, with or without subsequent evaporation of the solvent. The benzofuranone and organophosphorus stabilizer can also be added to the polyolefin in the form of a masterbatch, which contains the additive in a concentration of, for example, about 2 to 40 weight percent, based on the total weight of the masterbatch. In the case of a masterbatch form, the polymer in the masterbatch need not be the same as the polyolefin. The molding can be carried out using known mixers, such as mixers, kneaders or extruders.
The benzofuranone and the organophosphorus stabilizer may be premixed or added separately. The benzofuranones and organophosphorus stabilizers can also be added before or during polymerization or before crosslinking. The benzofuranones and organophosphorus stabilizers can be incorporated into the polyolefin in pure form or encapsulated in waxes, oils or polymers.
Benzofuranones and organophosphorus stabilizers can also be sprayed onto polyolefins. They are capable of diluting other additives or their melts so that they can also be sprayed onto the polyolefin together with these additives.
In a particular embodiment, the benzofuranone additive and the organophosphorus stabilizer are incorporated into the polyolefin by melt blending them in an extruder. The benzofuranone and the organophosphorus stabilizer can be added together or separately.
In some embodiments, the process for preparing the polyolefin composition comprises detecting the weight of the raw materials and then dry blending the raw material components. This mixture can be fed into a screw extruder at a constant feed rate to extrude the material into the desired form, followed by water cooling and drying.
Another subject of the invention is an article, for example a shaped article, comprising the polyolefin composition of the invention. Examples of the shaped article include, but are not limited to, those listed in the following items I-1) to IIV-8).
I-1) flotation devices, marine applications, pontoons, buoys, plastics or composites for bridges or piers, boats, kayaks, oars and beach reinforcements.
I-2) automotive applications, interior trim applications, exterior trim applications, such as bumpers, instrument panels, batteries, rear and front linings, molded parts under hoods, trunk linings, inner liners, airbag covers, electronic moldings for fittings (lamps), panels for instrument panels, headlamp lenses, instrument panels, exterior linings, cushions, automotive lamps, headlamps, parking lamps, tail lamps, parking lamps, interior panels and exterior panels; a door panel; a gas tank; a glass front; a rear windshield; a chair back; exterior panels, wire insulation, profile extrusions for sealing, cladding, lamp frames, chassis components, exhaust systems, fuel filters/fillers, fuel pumps, fuel tanks, body side moldings, convertible tops, rear view mirrors, exterior trim panels, fasteners/accessories, front end modules, glass, hinges, locking systems, luggage/roof racks, stamped/pressed parts, seals, side impact protection, silencers/sound insulators and awnings.
I-3) road traffic equipment, such as signs, posters for road marking, vehicle accessories, warning triangle, medical kit, helmets, tires.
I-4) installations, including interior furnishings, for aircraft, railways, motor vehicles (cars, motorcycles, trucks).
I-5) devices for space applications, such as rockets and satellites, for example reentry guards.
I-6) devices for construction and related, mining applications, sound insulation systems, street shelters and coverings.
II-1) devices, housings and covers in conventional and electronic/electrical appliances (personal computers, telephones, cell phones, printers, television sets, video equipment), flowerpots, satellite TV transmitting and receiving equipment.
II-2) sheaths for other materials such as iron or textiles.
II-3) devices for the electronics industry, such as insulation for plugs, in particular computer plugs, housings for electronic and electrical components, printing plates, and materials for electronic data storage, such as chips, check cards and credit cards.
II-4) electrical appliances, such as washing machines, vacuum cups, ovens (microwave ovens), dishwashers, mixers and irons.
II-5) covers for lamps (e.g. street lamps, lamp covers).
II-6) applications in wires and cables (semi-conductors, insulation and cable sheathing).
II-7) foils for condensers, refrigerators, heating devices, air conditioners, encapsulated electronics, semiconductors, coffee makers and vacuum cleaners.
III-1) technical articles, such as cogwheels (gears), sliding fittings, gaskets, screws, bolts, handles and grips.
III-2) rotating vanes, ventilators and windmill vanes, solar plants, swimming pools, pool covers, pool liners, closets, wardrobes, partition walls, slat walls, folding walls, roofs, shutters (e.g., roller blinds), fittings, connections between pipes, sleeves, and conveyor belts.
III-3) sanitary articles, such as tridimensional bathrooms, toilet seats, lids and sinks.
III-4) hygiene articles, such as diapers (babies, adults), feminine hygiene articles, shower curtains, brushes, mats, basins, portable toilets, toothbrushes and bed boards.
III-5) pipes for water, waste water and chemicals (crosslinked or uncrosslinked), pipes for protecting electric wires and cables, pipes for gas, oil and sewage, materials for drainage systems, sewer pipes and drainage systems.
III-6) profiles (window panes) and wall panels with any geometry.
III-7) glass substitutes, such as extruded or coextruded sheets, glazes for buildings (monolithic, double-walled or multi-walled), for aircraft, schools, extruded sheets, window films for architectural glazing, trains, transportation, sanitary and greenhouse.
III-8) boards (walls, cutting boards), extrusion-coatings (photographic paper, tetra pack and pipe coatings), basements, wood substitutes, plastic panels, wood composites, walls, surfaces, furniture, decorative foils, floor coverings (interior and exterior applications), floors, sailboards and tiles.
III-9) inlet and outlet manifolds.
III-10) applications of cement, concrete, composite materials, and coverings, siding and cladding, handrails, balustrades, kitchen worktops, roofing sheets, bricks, and rubberized canvas.
IV-1) boards (walls and cutting boards), trays, artificial turf, synthetic materials (e.g. Astro-
Figure BDA0002396795310000571
) Artificial coverings for sports tracks (sports), artificial floors for sports tracks (sports) and adhesive tapes.
IV-2) woven fabrics, continuous staple fibers (carpet/hygiene article/agrotextiles/monofilaments; a filter material; rags/curtains (shades)/medical applications), body fibers (applications such as gowns/protective clothing), nets, ropes, cables, strings, threads, safety seat belts, outerwear, underwear, gloves; a boot; rubber boots, underwear, clothing, swimwear, sportswear, umbrellas (parasol, canopy), parachutes, paragliders, sails, "balloon silk fabrics", camping supplies, tents, air beds, sun beds, flexible freight bags and bags. Non-woven fabrics, such as medical and related apparel, industrial apparel, outdoor fabrics, upholstery and structural fabrics.
IV-3) membranes, barriers, coverings and sealing materials for roofs, tunnels, storehouses, ponds, warehouses, wall covering membranes, agricultural membranes, swimming pools, curtains (shades)/sun-shading goods, awnings, canopies, wallpaper, food packaging and packaging (flexible and solid), medical packaging (flexible & solid), airbags/safety belts, arm-rests and head rests, carpets, center consoles, instrument panels, cockpit, doors, roof control modules, door frames, headcables, interior lighting, interior mirrors, storage panels, trunk lids, seats, steering columns, steering devices, fabrics and rear cabin trim panels.
V) films (packaging, warehouse, laminating, agriculture and horticulture (greenhouse covering, tunnels, low walk-in tunnels, high tunnels, pavement coverings, storage, silo bags, silo stretchings, fumigation, air bubbles, tent strips, sun-packs, heat packs, care products, film tubes), greenhouses, pavement coverings, tunnels, storage), wrappings, swimming pools, waste bags, wallpaper, stretch film, Raffia, desalination films, batteries and connectors. The film may have a single layer structure or a multilayer structure, for example, 3,5 or 7 layers. Examples include the film structure represented by A-B-A, A-B-C, A-B-C-B-A, A-B-C-B-D, A-B-C-D-C-B-A, A-A-B-C-B-A-A, wherein A, B, C and D represent different polymers or tackifiers. These layers may also be arranged to provide a film with an even number of layers, i.e. 2,4 or 6 layers, for example A-A-B-A, A-A-B-B, A-A-B-A-A, A-B-B-A-A, A-A-B-C-B, A-A-B-C-A-A, etc.
VI-1) food packaging and wrapping (flexible and solid), bottles.
VI-2) storage systems, such as boxes (feedboxes), luggage, cases, household cases, cots, shelves, rails, screw boxes, bags and cans.
VI-3) kits, syringes, medical devices, containers for any transport, waste baskets and waste buckets, waste bags, bins, trash cans, bin liners, wheel hoppers, conventional containers, tanks for water/waste water/chemicals/gas/oil/gasoline/diesel; can liners, boxes, feedboxes, battery boxes, sinks, medical devices such as pistons, ophthalmic applications, diagnostic devices, and blister packs for pharmaceuticals.
VII-1) extrusion coating (photographic paper, tetra pack, tube coating), any type of household item (e.g. household appliance, thermos bottle/hanger), fastening systems, such as plugs, wire and cable clamps, zippers, partitions, locks and closure snaps.
VII-2) support devices, leisure articles, such as sports and health devices, gymnastic mats, ski shoes, ice skates, skis, sports shoes, remote surfaces (for example badminton grounds); screw caps, caps and stoppers for bottles and cans.
VII-3) conventional furniture, foamed articles (cushions, impact absorbers), foams, sponges, dishcloths, mats, garden chairs, gym chairs, tables, couches, toys, assembly kits (boards/pictures/balls), playhouses, siding and playcars.
VII-4) materials for optical and magnetic data storage.
VII-5) kitchen utensils (eating, drinking, cooking, storing).
VII-6) boxes for CDs, cassettes and video tapes; DVD electronics, office supplies of any kind (ball-point pens, stamp pads, mice, shelves, music tracks), bottles of any volume and content (beverages, detergents, cosmetics, including perfumes) and adhesive tapes.
VII-7) footwear (shoes/soles), insoles, overshoes, adhesives, structural adhesives, food boxes (fruits, vegetables, meat, fish), synthetic paper, bottle labels, couches, artificial joints (human body), printing plates (offset printing), printed circuit boards and display technology.
VII-8) use in filled polymers (talc, chalk)Clay (kaolin), wollastonite, pigment, carbon black and TiO2Mica, nanocomposite, dolomite, silicate, glass, asbestos).
In particular embodiments, the shaped article is a film, tube, profile, bottle, can, container, or fiber. Shaped articles may be prepared by molding, for example injection molding, blow molding, compression molding, rotational molding, slush molding or extrusion molding.
The methods and compositions of the present invention can provide excellent color properties and improved thermal stability of polyolefins during melt processing. Melt processing stability can be manifested in improved molecular weight retention and retention of polymer molecular structure.
The articles "a" and "an" herein mean one or more than one (e.g., at least one) of the grammatical subject matter. Any ranges mentioned herein are inclusive. The term "about" is used herein to describe and account for small fluctuations. For example, "about" can indicate that the value can be modified by 5%, ± 4%, ± 3%, ± 2%, ± 1%, ± 0.5%, ± 0.4%, ± 0.3%, ± 0.2%, ± 0.1% or ± 0.05%. All numerical values are modified by the term "about," whether or not explicitly indicated. A value modified by the term "about" includes the explicitly stated value. For example, "about 5.0" includes 5.0.
The U.S. patents, U.S. patent applications, and published U.S. patent applications referred to in this discussion are incorporated herein by reference.
All parts and percentages are by weight unless otherwise indicated. Weight percent (wt%) is based on the entire composition without any volatiles, unless otherwise specified.
Examples
The following additives AO1 is a sterically hindered phenolic antioxidant, pentaerythritol tetrakis (3- (3, 5-di-tert-butyl-4-hydroxyphenyl) propionate), AO2 is octadecyl 3- (3, 5-di-tert-butyl-4-hydroxyphenyl) propionate, which is a sterically hindered phenolic antioxidant, Phos1-Phos6 is an organophosphorus stabilizer, tris (2, 4-di-tert-butylphenyl) phosphite (Phos1), tris (nonylphenyl) phosphite (Phos2), bis (2, 4-di-tert-butylphenyl) pentaerythritol diphosphite (Phos3), bis (2, 4-di-tert-butyl-6-methylphenyl) ethyl phosphite (Phos4), 2' -nitrilo [ triethyltris (3, 3', 5', tetra-tert-butyl-1, 1' -biphenyl-2, 2' -diyl) phosphite ] (Phos5), bis (2, 4-di- α -cumylphenyl) pentaerythritol diphosphite (Phos4, 4-propyl) phosphite (Phos7), a mixture of dimethyl-phenyl phosphites (Phos4, 4-propyl) and Phos7 are used in the examples.
The unit of additive loading is ppm by weight (parts per million), based on the weight of the polymer. When the total amount of phosphorus (P) is listed in the formulation, the unit of this amount is also reported as ppm by weight, based on the weight of the polymer.
The color change of the polymer sheet was measured according to ASTM-313 using a DCI SF600 spectrometer with a large area viewing angle; comprises a spectrum component; 2 degree observer. The color is expressed by the Yellowness Index (YI).
Melt flow rate retention was measured from the zero pass polymer sample and the 5 th pass extrudate. The melt flow rate was measured according to ASTM-1238 on a Tinius-Olsen extrusion plastograph at 190 ℃ under 2.16 kg; the units are grams of polymer flowing from a given die in 10 minutes.
Oxidative Induction Time (OIT) is a measure of the oxidative stability of a polymer. OIT was detected with a Differential Scanning Calorimeter (DSC). Scans were collected from 50 ℃ to 190 ℃ under nitrogen using a heating rate of 10 ℃/min, switched to oxygen, and held under isothermal conditions until catastrophic oxidation occurred. The time until catastrophic oxidation began to occur was reported (as observed as a strong exotherm) in minutes.
Example 1 m-LLDPE
Cast film grade metallocene linear low density polyethylene (m-LLDPE) was formulated with the following additives.
1)500ppm of Phos 1; 24ppm of P
2)1000ppm of Phos 1; 48ppm of P
3)400ppm of Phos 1; 100ppm of benzofuranone (109); 23ppm of P
4)375ppm of Phos 1; 125ppm of benzofuranone (109); 23ppm of P
5)425ppm of Phos 1; 125ppm of benzofuranone (109); 25ppm of P
6)450ppm of Phos 2; 100ppm of benzofuranone (109); 23ppm of P
7)187ppm of Phos 3; 100ppm of benzofuranone (109); 23ppm of P
8)304ppm of Phos 4; 100ppm of benzofuranone (109); 23ppm of P
9)187ppm of Phos 5; 100ppm of benzofuranone (109); 23ppm of P
10)264ppm of Phos 6; 100ppm of benzofuranone (109); 23ppm of P
These additives are blended with the particulate polymer without any stabilizing additives. In addition to the additives listed, all formulations were blended with 250ppm AO2 and 200ppm AO 1. The fully blended formulation was melt mixed in a twin screw extruder at 210 ℃ under nitrogen. The mixed formulation was extruded several times in a single-screw extruder equipped with a Maddock mixing section at 260 ℃ with aeration. The pelletized sample of extrudate from the third pass was compression molded into a 3.2mm plaque. The results are shown below.
Figure BDA0002396795310000611
Example 2 blow Molding grade HMW Cr-HDPE
Blow molding grade chromium catalyzed high molecular weight high density polyethylene (HMW Cr-HDPE) with a High Load Melt Index (HLMI) of 5.5 was formulated with the following additives.
1)620ppm of Phos1
2)1250ppm of Phos1
3)375ppm of Phos 1; 125ppm of benzofuranone (109)
4)450ppm of Phos 1; 150ppm of benzofuranone (109)
5)375ppm of a 1:1 weight mixture of Phos1/Phos 6; 125ppm of benzofuranone (109)
6)375ppm of a 1:1 weight mixture of Phos1/Phos 3; 125ppm of benzofuranone (109)
These additives are blended with the particulate polymer without any stabilizing additives. All formulations were blended with 500ppm AO1 in addition to the listed additives. The fully blended formulation was melt mixed in a twin screw extruder at 210 ℃ under nitrogen. The granulated sample was compression molded into 3.2mm plaques. The results are shown below.
Figure BDA0002396795310000621
Example 3m-LLDPE
Blown film grade metallocene linear low density polyethylene (m-LLDPE) was formulated with the following additives.
1)500ppm of Phos 1; 24ppm of P
2)1000ppm of Phos 1; 48ppm of P
3)375ppm of Phos 1; 125ppm of benzofuranone (109); 23ppm of P
4)500ppm of Phos 2; 21ppm of P
5)1000ppm of Phos 2; 43ppm of P
6)375ppm of Phos 2; 125ppm of benzofuranone (109); 21ppm of P
7)500ppm of Phos 7; 24ppm of P
8)1000ppm of Phos 7; 48ppm of P
9)375ppm of Phos 7; 125ppm of benzofuranone (109); 22ppm of P
10)500ppm of Phos 8; 27ppm of P
11)1000ppm of Phos 8; 53ppm of P
12)375ppm of Phos 8; 125ppm benzofuranone (109); 25ppm of P
These additives are blended with the particulate polymer without any stabilizing additives. In addition to the additives listed, all formulations were blended with 500ppm zinc stearate and 500ppm AO 2. The fully blended formulation was melt mixed in a twin screw extruder at 210 ℃ under nitrogen. The mixed formulation was extruded several times in a single-screw extruder equipped with a Maddock mixing section at 260 ℃ with aeration. The pelletized sample of extrudate from the third pass was compression molded into a 3.2mm plaque. The results are shown below.
Figure BDA0002396795310000631
Example 4 blown film grade m-LLDPE
Blown film grade metallocene linear low density polyethylene (m-LLDPE) was formulated with the following additives.
1)500ppm AO 2; 0ppm of P
2)500ppm of Phos 1; 500ppm AO 2; 24ppm of P
3)1000ppm of Phos 1; 500ppm AO 2; 48ppm of P
4)375ppm of Phos 1; 500ppm AO 2; 125ppm of benzofuranone (109); 23ppm of P
5)450ppm of Phos 1; 500ppm AO 2; 150ppm of benzofuranone (109); 27ppm of P
6)600ppm of Phos 1; 150ppm of benzofuranone (109); 34ppm of P
7)800ppm of Phos 1; 200ppm of benzofuranone (109); 46ppm of P
These additives are blended with the particulate polymer without any stabilizing additives. All formulations were blended with 500ppm of zinc stearate in addition to the additives listed. The fully blended formulation was melt mixed in a twin screw extruder at 210 ℃ under nitrogen. The mixed formulation was extruded several times in a single-screw extruder equipped with a Maddock mixing section at 260 ℃ with aeration. The pelletized sample of extrudate from the third pass was compression molded into a 3.2mm plaque. The results are shown below.
Figure BDA0002396795310000641
Example 5zn-LLDPE
Blown film grade Ziegler-Natta linear low density polyethylene (zn-LLDPE) was formulated with the following additives.
1) - - - - -; 0ppm of P
2)500ppm of Phos 1; 24ppm of P
3)1000ppm of Phos 1; 48ppm of P
4)300ppm of Phos 1; 100ppm of benzofuranone (109); 18ppm of P
5)375ppm of Phos 1; 125ppm of benzofuranone (109); 23ppm of P
6)450ppm of Phos 1; 150ppm of benzofuranone (109); 27ppm of P
7)400ppm of benzofuranone (109); 15ppm of P
8)500ppm of benzofuranone (109); 19ppm of P
9)600ppm of benzofuranone (109); 22ppm of P
These additives are blended with the particulate polymer without any stabilizing additives. In addition to the additives listed, all formulations were blended with 450ppm of the 4/5 weight mixture of AO1/AO2 and 800ppm of zinc oxide. The fully blended formulation was melt mixed in a twin screw extruder at 210 ℃ under nitrogen. The mixed formulation was extruded several times in a single-screw extruder equipped with a Maddock mixing section at 260 ℃ with aeration. The pelletized sample of extrudate from the third pass was compression molded into a 3.2mm plaque. The results are shown below.
Figure BDA0002396795310000651
Example 6m-LLDPE
Cast film grade metallocene linear low density polyethylene (m-LLDPE) was formulated with the following additives.
1) - - - - -; 0ppm of P
2)500ppm of Phos 1; 24ppm of P
3)1000ppm of Phos 1; 48ppm of P
4)300ppm of Phos 1; 100ppm of benzofuranone (109); 18ppm of P
5)375ppm of Phos 1; 125ppm of benzofuranone (109); 23ppm of P
6)450ppm of Phos 1; 150ppm of benzofuranone (109); 27ppm of P
7)400ppm of benzofuranone (109); 15ppm of P
8)500ppm of benzofuranone (109); 19ppm of P
9)600ppm of benzofuranone (109); 22ppm of P
These additives are blended with the particulate polymer without any stabilizing additives. In addition to the additives listed, all formulations were blended with 450ppm of a 4/5 weight mixture of AO1/AO2, 300ppm of calcium stearate and 500ppm of hydrotalcite. The fully blended formulation was melt mixed in a twin screw extruder at 210 ℃ under nitrogen. The mixed formulation was extruded several times in a single-screw extruder equipped with a Maddock mixing section at 260 ℃ with aeration. The pelletized sample of extrudate from the third pass was compression molded into a 3.2mm plaque. The results are shown below.
Figure BDA0002396795310000661

Claims (24)

1. A composition, comprising:
i) a polyolefin,
ii) one or more benzofuranone compounds selected from the group consisting of formula I-p1, I-p2, I-o1, I-o2, I-m1, and I-m 2:
Figure FDA0002396795300000011
Figure FDA0002396795300000021
wherein
X and Z are independently P or P ═ O; y isp、YoAnd YmIs oxygen or represents a covalent bond;
when Y isp、YoAnd YmWhen is oxygen, R1pRepresents one of the sub-formulae II-p, II-o or II-m:
Figure FDA0002396795300000022
Figure FDA0002396795300000031
R1orepresents one of the sub-formulae II-o or II-m, R1mRepresents the sub-formula II-m, or
R1pAnd R2pTogether, R1oAnd R2oTogether with R1mAnd R2mTogether represent one of the sub-formulae III, IV or V:
Figure FDA0002396795300000032
or R1p、R1oAnd R1mIs unsubstituted or substituted by C1-C8Alkyl radical, C1-C8Alkoxy, halogen or C substituted by one phenyl group6-C10Aryl radical, C1-C18Alkyl radical, C3-C16Cycloalkyl radical, C7-C13Aralkyl radical, C2-C18Alkenyl, C interrupted by one or more oxygen atoms2-C30Alkyl, or C interrupted by a sulfur atom2-C16Alkyl radical, R2pRepresents one of the sub-formulae II-p, II-o or II-m, R2oRepresents one of the sub-formulae II-o or II-m, R2mRepresents the sub-formula II-m, or R2pAnd R1pTogether, R2oAnd R1oTogether with R2mAnd R1mTogether represent one of the sub-formulae III, IV or V, or R2p、R2oAnd R2mIs unsubstituted or substituted by C1-C8Alkyl radical, C1-C8Alkoxy, halogen or C substituted by one phenyl group6-C10Aryl radical, C1-C18Alkyl radical, C3-C16Cycloalkyl radical, C7-C13Aralkyl radical, C2-C18Alkenyl, C interrupted by one or more oxygen atoms2-C30Alkyl, or C interrupted by a sulfur atom2-C16An alkyl group; when Y isp、YoAnd YmWhen represents a covalent bond, R1pRepresents one of the sub-formulae II-p, II-o or II-m, R1oRepresents one of the sub-formulae II-o or II-m, R1mRepresents the sub-formula II-m, or R1p、R1oAnd R1mIs unsubstituted or substituted by C1-C8Alkyl radical, C1-C8Alkoxy, halogen or C substituted by one phenyl group6-C10Aryl radical, C1-C18Alkyl radical, C3-C16Cycloalkyl radical, C7-C13Aralkyl radical, C2-C18Alkenyl, C interrupted by one or more oxygen atoms2-C30Alkyl, or C interrupted by a sulfur atom2-C16Alkyl radical, R2p、R2oAnd R2mIs unsubstituted or substituted by C1-C8Alkyl radical, C1-C8Alkoxy, halogen or C substituted by one phenyl group6-C10Aryl, or halogen; r4、R5、R6And R7Each independently is hydrogen or C1-C8Alkyl radical, Rp2、Rp3、Rp5And Rp6Each independently is hydrogen or C1-C8Alkyl radical, Ro1、Ro2、Ro5And Ro6Each independently is hydrogen or C1-C8An alkyl group, a carboxyl group,
Rm1、Rm3、Rm5and Rm6Each independently is hydrogen or C1-C8Alkyl radical, Ra1、Ra2、Ra3And Ra4Each independently is hydrogen or C1-C8Alkyl radical, Rb1、Rb2、Rb3、Rb4、Rb5And Rb6Each independently is hydrogen or C1-C8Alkyl, and Rc1、Rc2、Rc3And Rc4Each independently is hydrogen or C1-C8An alkyl group, a carboxyl group,
and
iii) one or more organophosphorus stabilizers.
2. The composition of claim 1, wherein the polyolefin comprises polypropylene.
3. The composition of claim 1, wherein the polyolefin comprises polyethylene.
4. The composition of claim 1, wherein the organophosphorus stabilizer is selected from the group consisting of triphenylphosphite, diphenylalkylphosphite, phenyldialkylphosphite, tris (2, 4-di-tert-butylphenyl) phosphite, tris- (sec-butylphenyl) phosphite, tris (nonylphenyl) phosphite, trilauryl phosphite, trioctadecyl phosphite, distearylpentaerythritol diphosphite, bis (2, 4-di- α -cumylphenyl) pentaerythritol diphosphite, diisodecyl pentaerythritol diphosphite, bis (2, 4-di-tert-butylphenyl) pentaerythritol diphosphite, bis (2, 6-di-tert-butyl-4-methylphenyl) pentaerythritol diphosphite, diisodecyloxy-pentaerythritol diphosphite, bis (2, 4-di-tert-butyl-6-methylphenyl) pentaerythritol diphosphite, bis (2,4, 6-tri-tert-butylphenyl) pentaerythritol diphosphite, tristearyl sorbitol phosphate, tetrakis (2, 4-di-tert-butylphenyl) 4,4' -diphenylene-diphosphonite, 6-isooctyloxy-2, 4,8, 10-tetra-tert-butylphenyl) pentaerythritol diphosphite, tris (2, 4' -di-tert-butyl-4 ' -dimethyl-3, 5' -di-octyl) phosphite, 2, 4' -di-tert-butyl-4 ' -dimethyl-4 ' -phenyl-4 ' -dimethyl-phenyl-phosphite, 3' -di-octyl-4 ' -tetra-3 ' -dimethyl-3-o-1, 5' -phenyl-di-dimethyl-1, 4' -tetra-butyl-4 ' -dimethyl-o-phosphite, 5' -phenyl-diphenyl-4 ' -dimethyl-1, 4' -dimethyl-o-1, 4' -phenyl-diphenyl-o-2, 4' -dimethyl-1, 4' -phenyl-diphenyl-dimethyl-phosphite, 4' -dimethyl-phenyl-1, 4' -dimethyl-o-1, 4' -phenyl-dimethyl-o-phenyl-1, 4' -phenyl-diphenyl-1, 4' -dimethyl-phosphite, 4' -phenyl-o-dimethyl-o-1 ' -phenyl-1, 4' -diphenyl-phosphite, 4' -dimethyl-diphenyl-o-1, 4' -diphenyl-1, 4' -phenyl-1, 4' -dimethyl-phenyl-1, 4' -diphenyl-dimethyl-diphenyl-phenyl-diphenyl-,
Figure FDA0002396795300000051
Figure FDA0002396795300000061
5. the composition of claim 1 wherein the organophosphorus stabilizer is selected from the group consisting of tris (2, 4-di-tert-butylphenyl) phosphite, tris (nonylphenyl) phosphite, bis (2, 4-di-tert-butylphenyl) pentaerythritol diphosphite, bis (2, 4-di-tert-butyl-6-methylphenyl) ethyl phosphite, 2,2', 2 "-nitrilo [ triethyltris (3, 3', 5' -tetra-tert-butyl-1, 1' -biphenyl-2, 2' -diyl) phosphite ] and bis (2, 4-di- α -cumylphenyl) pentaerythritol diphosphite.
6. The composition of claim 1 comprising tris- (2, 4-di-tert-butylphenyl) phosphite.
7. The composition according to any one of claims 1-6, further comprising one or more compounds selected from the group consisting of sterically hindered phenolic antioxidants.
8. The composition of any one of claims 1-6, further comprising one or more hindered phenolic antioxidants selected from β - (3, 5-di-tert-butyl-4-hydroxyphenyl) propionate.
9. The composition of any one of claims 1-6, wherein the composition is substantially free of hindered phenol antioxidants.
10. The composition of any of claims 1-6, wherein the one or more benzofuranone compounds are present in an amount of about 20 to 1000ppm by weight, based on the weight of the polyolefin.
11. The composition of any of claims 1-6, wherein the one or more organophosphorus stabilizers are present in an amount of about 20 to 1000ppm by weight, based on the weight of the polyolefin.
12. The composition of any of claims 1-6, wherein the weight/weight ratio between one or more benzofuranone compounds and one or more organophosphorus stabilizers is from about 0.05 to about 1.0.
13. The composition of any one of claims 1-6, wherein the benzofuranone compound is selected from the group consisting of formula I-p1, I-p2, and I-o 1.
14. The composition of any one of claims 1-6, wherein in the benzofuranone compound, X and Z are P, and Y is O.
15. The composition of any one of claims 1-6, wherein the benzofuranone compound is a compound of formula I-p1, I-p2, I-o1, I-o2, I-m1, or I-m2, wherein Y isp、YoAnd YmIs oxygen or represents a covalent bond; when Y isp、YoAnd YmWhen is oxygen, R1pRepresents one of the sub-formulae II-p, II-o or II-m, R1oRepresents one of the sub-formulae II-o or II-m, R1mRepresents the sub-formula II-m, or R1pAnd R2pTogether, R1oAnd R2oTogether with R1mAnd R2mTogether represent one of the sub-formulae III, IV or V, or R1p、R1oAnd R1mIs unsubstituted or substituted by C1-C8Alkyl radical, C1-C8Alkoxy, halogen or C substituted by one phenyl group6-C10Aryl radical, C1-C18Alkyl radical, C3-C16Cycloalkyl radical, C7-C13Aralkyl radical, C2-Cis alkenyl, C interrupted by one or more oxygen atoms2-C30Alkyl, or C interrupted by a sulfur atom2-C16Alkyl radical, R2pRepresents one of the sub-formulae II-p, II-o or II-m, R2oRepresents one of the sub-formulae II-o or II-m, R2mRepresents the sub-formula II-m, or R2pAnd R1pTogether, R2oAnd R1oTogether with R2mAnd R1mTogether represent one of the sub-formulae III, IV or V, or R2p、R2oAnd R2mIs unsubstituted or substituted by C1-C8Alkyl radical, C1-C8Alkoxy, halogen or C substituted by one phenyl group6-C10Aryl radical, C1-C18Alkyl radical, C3-C16Cycloalkyl radical, C7-C13Aralkyl radical, C2-C18Alkenyl, C interrupted by one or more oxygen atoms2-C30Alkyl, or C interrupted by a sulfur atom2-C16An alkyl group; when Y isp、YoAnd YmWhen represents a covalent bond, R1pRepresents one of the sub-formulae II-p, II-o or II-m, R1oRepresents one of the sub-formulae II-o or II-m, R1mRepresents the sub-formula II-m, or R1p、R1oAnd R1mIs unsubstituted or substituted by C1-C8Alkyl radical, C1-C8Alkoxy, halogen or C substituted by one phenyl group6-C10Aryl radical, C1-C18Alkyl radical, C3-C16Cycloalkyl radical, C7-C13Aralkyl radical, C2-C18Alkenyl, C interrupted by one or more oxygen atoms2-C30Alkyl, or C interrupted by a sulfur atom2-C16Alkyl radical, R2p、R2oAnd R2mIs unsubstituted or substituted by C1-C8Alkyl radical, C1-C8Alkoxy, halogen or C substituted by one phenyl group6-C10Aryl, or halogen; r4And R6Is hydrogen, R5And R7Each independently is hydrogen or C1-C8Alkyl radical, Rp2And Rp6Each independently is hydrogen or C1Alkyl radical, Rp3And Rp5Are each independently hydrogen or C1-C4Alkyl radical, Ro1And Ro6Each independently is hydrogen or C1-C8Alkyl radical, Ro2Is hydrogen or C1Alkyl radical, Ro5Is hydrogen or C1-C4Alkyl radical, Rm1Is hydrogen or C1Alkyl radical, Rm3And Rm5Each independently is hydrogen or C1-C4Alkyl radical, Rm6Is hydrogen or C1-C8Alkyl radical, Ra1、Ra2、Ra3And Ra4Each independently is hydrogen or C1-C4Alkyl radical, Rb1、Rb2、Rb3、Rb4、Rb5And Rb6Each independently is hydrogen or C1-C4Alkyl, and Rc1、Rc2、Rc3And Rc4Each independently is hydrogen or C1-C4An alkyl group.
16. The composition of any one of claims 1-6, wherein benzofuranone is a compound of formula I-p1, I-p2, I-o1, I-o2, I-m1, or I-m2, wherein Yp、YoAnd YmIs oxygen or represents a covalent bond; when Y isp、YoAnd YmWhen is oxygen, R1pRepresents one of the sub-formulae II-p, II-o or II-m, R1oRepresents one of the sub-formulae II-o or II-m, R1mRepresents the sub-formula II-m, or R1pAnd R2pTogether, R1oAnd R2oTogether with R1mAnd R2mTogether represent one of the sub-formulae III, IV or V, or R1p、R1oAnd R1mIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C10Aryl radical, C1-C18Alkyl or C3-C16Cycloalkyl radical, and R2pRepresents one of the sub-formulae II-p, II-o or II-m, R2oRepresents one of the sub-formulae II-o or II-m, R2mRepresents the sub-formula II-m, or R2pAnd R1pTogether, R2oAnd R1oTogether with R2mAnd R1mTogether represent one of the sub-formulae III, IV or V, or R2p、R2oAnd R2mIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C10Aryl radical, C1-C18Alkyl or C3-C16A cycloalkyl group; when Y isp、YoAnd YmWhen represents a covalent bond, R1pRepresents one of the sub-formulae II-p, II-o or II-m, R1oRepresentsOne of the sub-formulae II-o or II-m, R1mRepresents the sub-formula II-m, or R1p、R1oAnd R1mIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C10Aryl radical, C1-C18Alkyl or C3-C16Cycloalkyl radical, and R2p、R2oAnd R2mIs unsubstituted or substituted by C1-C8Alkyl substituted C6-C10Aryl, or fluoro.
17. The composition of any one of claims 1-6, wherein benzofuranone is a compound of formula I-p1, I-p2, I-o1, or I-o2, wherein YpAnd YoIs oxygen or represents a covalent bond; when Y ispAnd YoWhen is oxygen, R1p、R2p、R1oOr R2oDoes not represent sub-formula II-m; when Y ispAnd YoWhen represents a covalent bond, R1pOr R1oDoes not represent sub-formula II-m.
18. The composition of any one of claims 1-6, wherein benzofuranone is a compound of formula I-p1, I-p2, I-o1, or I-o2, wherein YpAnd YoIs oxygen, R1pAnd R2pTogether with R1oAnd R2oTogether represent one of the sub-formulae III, IV or V, R2pAnd R1pTogether with R2oAnd R1oTogether represent one of the sub-formulae III, IV or V, R4、R5、R6And R7Each independently is hydrogen or C1-C8Alkyl radical, Rp2、Rp3、Rp5And Rp6Each independently is hydrogen or C1-C8Alkyl radical, Ro1、Ro2、Ro5And Ro6Each independently is hydrogen or C1-C8Alkyl radical, Ra1、Ra2、Ra3And Ra4Each independently is hydrogen or C1-C8Alkyl radical, Rb1、Rb2、Rb3、Rb4、Rb5And Rb6Each independently of the otherGround is hydrogen or C1-C8Alkyl, and Rc1、Rc2、Rc3And Rc4Each independently is hydrogen or C1-C8An alkyl group.
19. The composition of any one of claims 1-6, wherein benzofuranone is a compound selected from formulas (101) to (133):
Figure FDA0002396795300000091
Figure FDA0002396795300000101
Figure FDA0002396795300000111
Figure FDA0002396795300000121
Figure FDA0002396795300000131
Figure FDA0002396795300000141
Figure FDA0002396795300000151
Figure FDA0002396795300000161
Figure FDA0002396795300000171
Figure FDA0002396795300000181
Figure FDA0002396795300000191
Figure FDA0002396795300000201
20. a shaped article comprising the composition of any one of claims 1-6.
21. A method of making the shaped article of claim 20, comprising melt blending the composition.
22. An additive composition comprising ii) one or more benzofuranone compounds selected from the group consisting of formula I-p1, I-p2, I-o1, I-o2, I-m1, and I-m2 according to claim 1 and iii) one or more organophosphorus stabilizers.
23. The additive composition of claim 22, wherein the weight/weight ratio between one or more benzofuranone compounds and one or more organophosphorus stabilizers is from about 0.05 to about 1.0.
24. A method of stabilizing polyolefins against the adverse effects of heat, light and oxygen, which comprises incorporating into the polyolefin ii) one or more benzofuranone compounds of formula I-p1, I-p2, I-o1, I-o2, I-m1 and I-m2 according to claim 1 and iii) one or more organophosphorus stabilizers.
CN201880056779.5A 2017-07-06 2018-07-03 Stabilized polyolefin compositions comprising benzofuranones and organophosphorus stabilizers Pending CN111051322A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP17180079.0 2017-07-06
EP17180079 2017-07-06
US201862691193P 2018-06-28 2018-06-28
US62/691,193 2018-06-28
PCT/US2018/040694 WO2019010166A1 (en) 2017-07-06 2018-07-03 Stabilized polyolefin compositions comprising benzofuranones and organophosphorus stabilizers

Publications (1)

Publication Number Publication Date
CN111051322A true CN111051322A (en) 2020-04-21

Family

ID=67702079

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880056779.5A Pending CN111051322A (en) 2017-07-06 2018-07-03 Stabilized polyolefin compositions comprising benzofuranones and organophosphorus stabilizers

Country Status (10)

Country Link
EP (1) EP3649139A4 (en)
JP (1) JP2020526610A (en)
KR (1) KR20200027523A (en)
CN (1) CN111051322A (en)
AU (2) AU2018298021B2 (en)
BR (1) BR112020000132A2 (en)
CA (1) CA3068831A1 (en)
MX (1) MX2020000231A (en)
TW (1) TW201920427A (en)
ZA (1) ZA202000592B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112292382A (en) * 2018-06-21 2021-01-29 巴斯夫欧洲公司 3-phenylbenzofuran-2-one diphosphate derivatives as stabilizers

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020000233A (en) * 2017-07-06 2020-08-17 Basf Se Stabilized polyolefin compositions comprising benzofuranones and hindered phenolic antioxidants.
US11309212B2 (en) * 2020-07-30 2022-04-19 Taiwan Semiconductor Manufacturing Co., Ltd. Semiconductor device structure and methods of forming the same

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308901A (en) * 1988-07-25 1994-05-03 General Electric Company 3-9-diphosphaspiroundecane-stabilized polymer compositions
CN1281002A (en) * 1999-07-14 2001-01-24 三井化学株式会社 Polyolefin resin composition
US20070021537A1 (en) * 2005-07-21 2007-01-25 Chafin Laura F Stabilization of polyolefins with liquid tris-(mono-alkyl)phenyl phosphites
CN105960432A (en) * 2014-02-17 2016-09-21 巴斯夫欧洲公司 3-phenyl-benzofuran-2-one derivatives containing phosphorus as stabilizers
WO2017025431A1 (en) * 2015-08-10 2017-02-16 Basf Se 3-phenyl-benzofuran-2-one derivatives containing phosphorus as stabilizers
CN106574090A (en) * 2014-08-05 2017-04-19 巴斯夫欧洲公司 3-phenyl-benzofuran-2-one diphosphite derivatives as stabilizers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020000233A (en) * 2017-07-06 2020-08-17 Basf Se Stabilized polyolefin compositions comprising benzofuranones and hindered phenolic antioxidants.
WO2019010167A1 (en) * 2017-07-06 2019-01-10 Basf Se Stabilized polyolefin compositions comprising benzofuranones and hindered phenolic antioxidants
MX2021000081A (en) * 2018-06-21 2021-03-25 Basf Se 3-phenyl-benzofuran-2-one diphosphate derivatives as stabilizers.

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308901A (en) * 1988-07-25 1994-05-03 General Electric Company 3-9-diphosphaspiroundecane-stabilized polymer compositions
CN1281002A (en) * 1999-07-14 2001-01-24 三井化学株式会社 Polyolefin resin composition
US20070021537A1 (en) * 2005-07-21 2007-01-25 Chafin Laura F Stabilization of polyolefins with liquid tris-(mono-alkyl)phenyl phosphites
CN105960432A (en) * 2014-02-17 2016-09-21 巴斯夫欧洲公司 3-phenyl-benzofuran-2-one derivatives containing phosphorus as stabilizers
CN106574090A (en) * 2014-08-05 2017-04-19 巴斯夫欧洲公司 3-phenyl-benzofuran-2-one diphosphite derivatives as stabilizers
WO2017025431A1 (en) * 2015-08-10 2017-02-16 Basf Se 3-phenyl-benzofuran-2-one derivatives containing phosphorus as stabilizers

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112292382A (en) * 2018-06-21 2021-01-29 巴斯夫欧洲公司 3-phenylbenzofuran-2-one diphosphate derivatives as stabilizers

Also Published As

Publication number Publication date
TW201920427A (en) 2019-06-01
EP3649139A4 (en) 2021-05-05
JP2020526610A (en) 2020-08-31
AU2022203873A1 (en) 2022-06-23
EP3649139A1 (en) 2020-05-13
CA3068831A1 (en) 2019-01-10
AU2018298021A1 (en) 2020-01-30
MX2020000231A (en) 2020-09-25
AU2018298021B2 (en) 2023-02-23
KR20200027523A (en) 2020-03-12
BR112020000132A2 (en) 2020-07-07
ZA202000592B (en) 2021-07-28

Similar Documents

Publication Publication Date Title
US10934423B2 (en) Stabilized polyolefin compositions comprising benzofuranones and organophosphorus stabilizers
AU2018297119B2 (en) Stabilized polyolefin compositions comprising benzofuranones and hindered amine light stabilizers
AU2018298022B2 (en) Stabilized polyolefin compositions comprising benzofuranones and hindered phenolic antioxidants
CN111051322A (en) Stabilized polyolefin compositions comprising benzofuranones and organophosphorus stabilizers
CN111406061A (en) Stabilized polyolefin compositions comprising benzofuranones and acid scavengers

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20200421

WD01 Invention patent application deemed withdrawn after publication